[go: up one dir, main page]

WO2006088165A1 - Gene detection reagent and the use thereof - Google Patents

Gene detection reagent and the use thereof Download PDF

Info

Publication number
WO2006088165A1
WO2006088165A1 PCT/JP2006/302896 JP2006302896W WO2006088165A1 WO 2006088165 A1 WO2006088165 A1 WO 2006088165A1 JP 2006302896 W JP2006302896 W JP 2006302896W WO 2006088165 A1 WO2006088165 A1 WO 2006088165A1
Authority
WO
WIPO (PCT)
Prior art keywords
region
nucleic acid
gene detection
target nucleic
detection reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2006/302896
Other languages
French (fr)
Japanese (ja)
Inventor
Yasuhiro Aoyama
Shinsuke Sando
Atsushi Narita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyoto University NUC
Original Assignee
Kyoto University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto University NUC filed Critical Kyoto University NUC
Priority to JP2007503761A priority Critical patent/JPWO2006088165A1/en
Publication of WO2006088165A1 publication Critical patent/WO2006088165A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Definitions

  • the present invention relates to a gene detection reagent, kit, and gene detection method for use in examining the presence of a foreign gene or structural abnormality of a gene.
  • Genetic testing can be divided into those that examine the presence of foreign genes that do not exist in the self and those that analyze genetic structural abnormalities. Examples of testing for the presence of foreign genes include identification of microorganisms that are difficult to culture and detection of pathogenic microorganisms during antibiotic treatment and early infection. Examples of genetic structural abnormality tests include tests for definitive diagnosis of genetic diseases, prediction tests for genetic diseases, tests that do not affect phenotype, and DNA polymorphism tests (parent-child test and forensic test). .
  • PCR was performed on a test sample using a PCR primer capable of amplifying the target gene, and the presence or mutation of the gene was detected by a method of sequencing the PCR product.
  • a reagent capable of genetic diagnosis in the state of the cell without extracting the gene from the cell has been proposed, and a typical example thereof is a molecular beacon.
  • a reagent for example, an oligonucleotide comprising a loop portion complementary to a target sequence and stem-forming sequences present at both ends thereof, a fluorescent dye is bound to one end, and a quencher is bound to the other end.
  • FIG. 9 shows a method for detecting a target nucleic acid using this molecular beacon.
  • the DNAzyme has two regions complementary to the target nucleic acid sequence on both sides of the loop portion that exhibits catalytic activity bound to a divalent metal ion, and hybridizes with the target nucleic acid in these two regions. It is thought to cut it at the loop.
  • the molecular beacon described in this document has a stem-loop structure formed using such a target binding region of one of the DNAzymes.
  • the loop portion has a sequence complementary to the target nucleic acid sequence.
  • this molecule forms a stem loop structure in the absence of the target nucleic acid, the DNAzyme cannot bind to the target nucleic acid, and the cleavage activity is not expressed.
  • the target nucleic acid is hybridized in the loop region, the loop opens, and the DNA zym binds to the target nucleic acid and the cleavage activity is expressed. By detecting this cleavage activity, the presence or absence of a sequence that can hybridize to the loop portion can be confirmed.
  • this method also has low detection sensitivity because it detects the cleavage activity of the molecular beacon molecule itself.
  • Non-Patent Document 3 reports that an enzyme is bound to an inhibitor via a single-stranded DNA fragment.
  • This molecular beacon contains a sequence complementary to the target nucleic acid sequence in the single-stranded DNA fragment, and when the target nucleic acid is not present, the single-stranded DNA fragment is flexible, so that the inhibitor interacts with the enzyme.
  • the part becomes rigid and extends, so that the inhibitor is removed from the enzyme and the enzyme activity is expressed. Since this molecular beacon detects the conversion of the substrate by the enzyme, the detection sensitivity is increased accordingly.
  • this molecule requires time and labor to bind dissimilar substances such as enzyme proteins, nucleic acids, and low molecular weight compounds.
  • Patent Document 1 uses RNA called a riboregulator to control the on / off of translation start of a specific gene to control the expression of the specific protein and elucidate the function of the protein in vivo. Tell me how to do it.
  • the riboregulator in this document is an mRNA molecule containing a ribosome binding region (RBS), an initiation codon, and a green fluorescent protein coding region, and having a “cis repressive RNA” region upstream of RBS.
  • RBS ribosome binding region
  • the cis-repressive RNA region consists of a sequence that can hybridize with RBS within the molecule. Normally, since this region and RBS are hybridized, the ribosome does not bind to RBS and is not translated into green fluorescent protein. Furthermore, cis-reactive RNA and RBS are dissociated by the “transactivating RNA” having a complementary region in the cis-reactive RNA region and hybridized to the cis-reactive RNA, which translates into a green fluorescent protein. Is called.
  • the transactivating RNA must have the same sequence as the ribosome binding region. Therefore, this riboregulator cannot detect the presence of an arbitrary base sequence.
  • Non-patent literature l Tyagi, S .; Kramer, F. R. Nat. Biotechnol. 1996, 14, 303.
  • Non-Patent Document 2 Stojanovic MN. Et al. ChemBioChem 2001, 2, 411
  • Non-Patent Document 3 Saghatelian, A. et al. J. Am. Chem. So 2003, 125, 344.
  • Patent Document 1 WO2004 / 046321
  • An object of the present invention is to provide a highly sensitive gene detection reagent comprising a nucleic acid, a kit including the reagent, and a method capable of detecting the presence or absence of a target gene with high sensitivity using a nucleic acid. .
  • the target nucleic acid can be detected and used as a gene detection reagent.
  • a ribosome binding region (hereinafter also referred to as “RBS”), a start codon, and a region encoding a reporter protein are provided in order from upstream, and the target nucleic acid sequence is hybridized upstream of the ribosome binding region.
  • RBS ribosome binding region
  • an RNA comprising a region (B) that can hybridize with a region containing a ribosome binding region via a region (A) can be hybridized with the region (B) and RBS.
  • the target nucleic acid and the region (A) are hybridized, so that this region becomes rigid and the loop extends, and as a result, the RBS and the region (B) are dissociated. This allows RBS to bind to RBS and initiates translation of the reporter gene.
  • the presence or absence of the target nucleic acid or the single nucleotide polymorphism in the test sample can be determined.
  • the present invention has been completed based on the above findings, and provides the following gene detection reagents, gene detection kits, and gene detection methods.
  • Item 1 A gene detection reagent comprising a region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, wherein higher-order structural changes are caused by hybridization with the target nucleic acid.
  • a reagent for gene detection that is induced and begins to translate into a reporter protein.
  • Item 2 The gene detection reagent according to Item 1, which has at least a region strength NA that codes at least a ribosome binding region, an initiation codon, and a reporter protein.
  • Item 3 The ribosome cannot bind to the ribosome binding region, and the conformation change induced by hybridization between the target nucleic acid and the region that can hybridize with the target nucleic acid.
  • Item 3. The gene detection reagent according to Item 2, which enables translation into a reporter protein.
  • Item 4 In order from upstream, ribosome binding region, start codon, and reporter protein The gene detection according to Item 3, further comprising a region capable of hybridizing with a region including the ribosome binding region via a region capable of hybridizing with the target nucleic acid sequence further upstream of the ribosome binding region. Reagent.
  • Item 5 The gene detection according to Item 4, wherein the ratio of the number of bases in the region hybridizable with the target nucleic acid sequence to the number of bases in the region hybridizable with the region including the ribosome binding region is 1 to 10 reagent.
  • Item 6 The gene detection reagent according to Item 4, wherein a region capable of hybridizing with a region containing a ribosome binding region comprises 5 to 30 bases, and a region capable of hybridizing with a target nucleic acid sequence comprises 5 to 60 bases.
  • Item 7 The gene detection reagent according to Item 1, wherein the region capable of hybridizing with the target nucleic acid sequence is a region complementary to the target nucleic acid sequence.
  • Item 8 The gene detection reagent according to Item 1, comprising a region that functions as a ribozyme that cleaves when hybridized with a target nucleic acid.
  • Item 9 The gene detection reagent according to Item 1, wherein the reporter protein is an enzyme.
  • Item 10 The reagent for gene detection according to Item 9, wherein the enzyme is involved in the production of a substance that generates visible light.
  • Item 11 A region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, wherein a conformational change induced by hybridization with the target nucleic acid is induced in the reporter protein.
  • RNA force S is in a state where ribosome cannot bind to the ribosome binding region.
  • Section 11 which enables the ribosome to bind to the higher-order structurally modified ribosome binding region induced by hybridization between the target nucleic acid and the target nucleic acid hybridizing region, thereby initiating translation into the reporter protein.
  • the RNA comprises a region encoding a ribosome binding region, an initiation codon, and a reporter protein in order from upstream, and a region capable of hybridizing with a target nucleic acid sequence further upstream of the ribosome binding region.
  • Item 14 The ratio of the number of bases in a region capable of hybridizing to a target nucleic acid sequence to the number of bases in a region capable of hybridizing with a region including a ribosome binding region is 1 to 10.
  • Item 15 The reagent for gene detection according to Item 13, wherein the region capable of hybridizing with the region including the ribosome binding region has a strength of 5 to 30 bases, and the region capable of hybridizing with the target nucleic acid sequence has 5 to 60 bases.
  • Item 16 The gene detection reagent according to Item 11, wherein the region capable of hybridizing with the target nucleic acid sequence is a region complementary to the target nucleic acid sequence.
  • Item 17 The reagent for gene detection according to Item 11, wherein the RNA includes a region that functions as a ribozyme that cleaves when hybridized with a target nucleic acid.
  • Item 18 The gene detection reagent according to Item 11, wherein the reporter protein is an enzyme.
  • Item 19 The gene detection reagent according to Item 18, wherein the enzyme is involved in the production of a substance that generates visible light.
  • Item 20 A gene detection kit comprising the gene detection reagent according to Item 1.
  • Item 21 The gene detection kit according to Item 20, further comprising a prokaryotic cell extract.
  • Item 22 The gene detection kit according to Item 20, further comprising an RNA degrading enzyme that specifically cleaves RNA hybridized with DNA.
  • Item 23 A gene detection kit comprising the gene detection reagent according to Item 11.
  • Item 24 The gene detection kit according to Item 23, further comprising a prokaryotic cell extract.
  • Item 25 The gene detection kit according to Item 23, further comprising an RNA degrading enzyme that specifically cleaves RNA hybridized with DNA.
  • Item 26 First step of mixing the test sample with the gene detection reagent according to Item 1, and the expression level of the reporter protein from the gene detection reagent in the absence of the test sample.
  • a gene detection method comprising a second step of determining the presence or absence of a target nucleic acid in a test sample by comparing the expression level of a reporter protein from the gene detection reagent according to 1.
  • Item 27 The method according to Item 26, wherein the reporter protein is expressed from the gene detection reagent in the presence of a prokaryotic cell extract.
  • Item 28 In the first step, the test sample, the gene detection reagent according to Item 1, and DN Item 27.
  • Item 29 The first step of mixing the test sample with the gene detection reagent according to Item 11, and the expression level of the reporter protein from the gene detection reagent in the absence of the test sample.
  • a gene detection method comprising a second step of determining the presence or absence of a target nucleic acid in a test sample by comparing with the expression level of a reporter protein from the gene detection reagent according to Item 11.
  • Item 30 The method according to Item 29, wherein the reporter protein is expressed from the gene detection reagent in the presence of a prokaryotic cell extract.
  • Item 31 In the first step, the test sample, the gene detection reagent according to Item 1, and DN
  • Item 30 The method according to Item 29, comprising a step of mixing A with an RNase that specifically cleaves the hybridized RNA.
  • Item 32 A first step of mixing a test sample, the gene detection reagent according to Item 1, and an RNase that specifically cleaves RNA hybridized with DNA, and a gene detection reagent The presence or absence of the target nucleic acid in the test sample is determined by comparing the expression level of the reporter protein with the expression level of the reporter protein from the gene detection reagent according to Item 1 in the absence of the test sample.
  • a method for detecting a single nucleotide polymorphism comprising the second step.
  • Item 33 A first step of mixing a test sample, the gene detection reagent according to Item 11, and an RNase that specifically cleaves RNA hybridized with DNA, and a gene detection reagent The presence or absence of the target nucleic acid in the test sample is determined by comparing the expression level of the reporter protein with the expression level of the reporter protein from the gene detection reagent described in Item 11 in the absence of the test sample.
  • a method for detecting a single nucleotide polymorphism comprising the second step.
  • Item 34 A nucleic acid comprising a region capable of hybridizing with a target nucleic acid sequence, a ribosome-binding region, an initiation codon, and a region encoding a reporter protein, wherein a conformation change is induced by hybridization with the target nucleic acid. And use as a reagent for gene detection of a nucleic acid that begins translation into a reporter protein.
  • RNA comprising a region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, Use as a reagent for gene detection of DNA that can be transcribed into RNA that initiates translation into a reporter protein by a conformational change induced by hybridisation.
  • the presence or absence of the target nucleic acid in the test sample is the presence or absence of translation from the RNA encoding the reporter protein into the reporter protein. appear.
  • This translation makes it possible to produce, for example, a multi-molecule reporter protein from one molecule of RNA, so that detection signals such as fluorescence can be amplified and detection sensitivity can be improved. Therefore, when the reagent of the present invention is used, it is not always necessary to amplify the nucleic acid in the test sample in advance by PCR or the like, and a cell lysate or the like can be directly used as the test sample.
  • the gene detection reagent comprising DNA, which is the second reagent of the present invention, a transcription process to DNA force RNA is added, and multiple molecules of RNA are generated from one DNA molecule. Also, since DNA is very stable, it is easy to use as a reagent.
  • the detection sensitivity is further enhanced because a plurality of substrates are converted from one molecule of enzyme.
  • the first of the present invention When the RNA of the reagent or the transcription product RNA of the second reagent RNA and the target nucleic acid (usually DNA) are hybridized, the RNA strand on the reagent side is cleaved and separated from the target nucleic acid.
  • the target nucleic acid can further bind to another RNA molecule, and similarly forms a cycle of cleavage of the reagent RNA and detachment from the target nucleic acid by the action of an enzyme.
  • the expression of one reporter gene can be amplified by successively hybridizing one molecule of the target nucleic acid with the reagent of the present invention. For this reason, detection sensitivity is further improved, and even when the target nucleic acid exists only in femtomolar order, gene detection can be performed without amplifying the target nucleic acid by PCR or the like.
  • the base sequence selectivity decreases as the region that can be hybridized with the target nucleic acid sequence becomes longer, that is, it can be detected when there is a mismatch.
  • the number of mismatched bases decreases.
  • the force that causes higher-order structural changes is weakened. There is a need. In this case, higher-order structural changes of non-specific RNA molecules are likely to occur.
  • the expression of the reporter gene is likely to occur due to nonspecific binding to the ribosomal force S ribosome binding region.
  • RNA that is bound when the target nucleic acid binds to the reagent RNA molecule.
  • Degradative enzymes cleave this RNA molecule to force conformational changes. That is, the state in which the ribosome binding region and the start codon hybridize with a complementary sequence is eliminated.
  • Hybridization will ensure higher-order structural changes.
  • a single base mismatch between the target nucleic acid and the region capable of hybridizing with the target nucleic acid can be detected more reliably, that is, a single nucleotide polymorphism can be detected.
  • the selectivity of single-base mismatch is also enhanced by the nature of RNase, which cleaves only perfectly matched base pairs.
  • the reagent RNA itself is a ribozyme that has the ability to self-cleavage when hybridized with the target nucleic acid, the same effect as that obtained when the RNase is used can be obtained.
  • Such gene detection using the reagent of the present invention can be referred to as "catalytic gene detection”.
  • the gene detection reagent of the present invention does not contain a synthetic compound such as a fluorescent substance or an enzyme inhibitor, and is composed only of nucleic acid, so that it is easy to manufacture. Moreover, it is only necessary to use the cell extract for use. It is also manufactured and used using only biological materials. Therefore, it can be applied to future living organisms.
  • FIG. 1 is a diagram showing the structure of MB-luciferase mRNA constructed in Example 1.
  • Fig. 2 Chemiluminescence intensity in the presence of flumati oligonucleotides and mismatched oligonucleotides when MB-luciferase mRNA is in the saddle type, in the absence of these targets It is a duff expressed as a relative value to the chemiluminescence intensity.
  • FIG. 3 MB luciferase expression Chemiluminescence intensity in the presence of flumati oligonucleotide and mismatched oligodeoxynucleotide when dsDNA is in a saddle type, chemistry in the absence of these targets It is a graph expressed as a relative value with respect to emission intensity.
  • FIG. 4 Chemiluminescence images of each reaction mixture were measured with Versadoc3000 in the presence of flumati oligonucleotides and mismatched oligonucleotides when MB luciferase-expressed dsDNA was in a saddle type. Is.
  • FIG. 5 Fluorescence image of MB-type MB-luciferase DNA transcribed using a cell-free transcription / translation system that does not contain ribosomes and tRNA in the presence of full-matched oligonucleotides and in the absence of target was measured with an ATTO densitograph.
  • FIG. 6 is a graph showing the relationship of chemiluminescence intensity to target amount.
  • FIG. 7 Chemoluminescence intensity in the presence of flumati oligonucleotide and 1-base GT mismatched oligonucleotide when MB-luciferase mRNA is in the saddle type, without target It is the graph represented with the relative value with respect to the chemiluminescence intensity of. Moreover, it is a graph which shows the effect by use of RNaseH.
  • FIG. 8 The chemiluminescence intensity in the presence of flumatsu oligodeoxynucleotide when MB-luciferase mRNA is of the vertical type, relative to the chemiluminescence intensity in the absence of the target. It is the represented graph. Also, it is a graph showing the effect of using RNaseH.
  • Fig. 9 shows the full-maturity of MB-galactosidase dsRNA in the vertical type. It is the graph which represented the light absorbency by nitrophenol in presence of an oligodeoxynucleotide with the relative value with respect to the light absorbency in case a target does not exist. Moreover, it is a graph which shows the effect by use of RNaseH.
  • Fig. (B) shows the result of visual observation of coloration by nitrophenol when ⁇ -galactosidase dsDNA is in the form of a cage.
  • FIG. 10 is a diagram for explaining gene detection using an example of a conventional molecular beacon.
  • FIG. 11 is a diagram for explaining gene detection using another example of a conventional molecular beacon.
  • the first gene detection reagent of the present invention comprises a region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, and a conformational change induced by hybridization with the target nucleic acid. Is a reagent that initiates translation into a reporter protein.
  • This reagent should have at least a ribosome-binding region, an initiation codon, and a region encoding a reporter protein having RNA power.
  • the other part may be any nucleic acid sequence such as RNA, DNA, or artificial nucleic acid.
  • the artificial nucleic acid include peptide nucleic acid (PNA; P-marked tide Nucleic Acid), LNA (Locked Nucleic Acid) and the like.
  • the structure of the reagent is not particularly limited as long as the target nucleic acid binds to a region capable of hybridizing with the target nucleic acid, so that a factor necessary for translation initiation can be bound to the reagent.
  • Examples of such a structure include a hairpin structure in which a region capable of hybridizing to a target nucleic acid is a loop and two regions existing on both sides form a stem by base pair formation.
  • Examples of the two regions forming the stem include a region capable of hybridizing with a ribosome binding region and a region including the same, a region capable of hybridizing with an initiation codon and a region including the region, and the like.
  • the ribosome binding region, the initiation codon, etc. are usually in a double-stranded state, so that factors necessary for translation cannot be bound, and the reporter There is virtually no translation into a single protein. Furthermore, when the target nucleic acid binds to a region that can hybridize with the target nucleic acid, this loop becomes rigid and extends, and as a result, all or part of the double strand of the stem is eliminated, and the factor force S required for translation initiation S It becomes able to bind to the ribosome binding region and initiation codon, and translation into the reporter protein begins.
  • a reagent in which a ribosome-binding region and a region capable of hybridizing with the ribosome-binding region form a double-stranded system encode a ribosome-binding region, an initiation codon, and a reporter protein in order from the upstream.
  • a reagent comprising a region, and a region further hybridized with a region containing a ribosome binding region via a region capable of hybridizing with a target nucleic acid sequence is provided further upstream of the ribosome binding region.
  • This reagent usually has a target nucleic acid-complementary region that hybridizes with a region that can hybridize with a region that includes the ribosome-binding region in the reagent molecule and a region that can hybridize with this region. It has a hairpin structure with a loop. If the target nucleic acid is present here, it hybridizes with the target nucleic acid complementary region, and the loop extends, resulting in a ribosome binding region force S1 strand state. This conformational change allows the ribosome to bind to the ribosome binding region and initiates translation into the reporter protein.
  • Ribosome binding regions include those that function in prokaryotic cells, those that function in eukaryotic cells, those derived from viruses, and the like.
  • the ribosome-binding region that functions in prokaryotic cells refers to a region consisting of a purine-rich sequence to which ribosomes can bind in prokaryotic cell mRNA, and generally consists of about 3 to 9 bases.
  • the ribosome binding region that functions in prokaryotic cells is also referred to as SD-coordinated IJ.
  • ribosome binding regions that function in eukaryotic cells include the Kozak sequence (5'—AGCCACCAUGG—3 ′) (SEQ ID NO: 1) and the ribosome internal recognition site (I RES: Internal Ribosome Entry Site). .
  • virus-derived ribosome binding region include a ribosome internal recognition site (IRES).
  • the viral I RES is a sequence contained in the viral RNA, which changes the three-dimensional structure of the liposome by binding to the host ribosome and usually initiates translation of the viral protein. With the gene detection reagent of the present invention, translation of a reporter protein can be initiated using viral IRES.
  • the number of bases present between the ribosome binding region and the start codon is not limited, but is preferred. 3 ⁇ : It should be about 12 bases away. Within this range, translation initiation starting with ribosome binding is efficiently performed.
  • the initiation codon is usually AUG, but other combinations 1J such as GUG can be used as long as it functions as an initiation codon.
  • reporter protein is not particularly limited, and any known reporter protein can be used without limitation.
  • Known reporter genes include, for example, a luciferase gene, a secreted alkaline phosphatase (SEAP) gene, a chloramphenicol acetyl transferase (CAT) gene, and a j3_galactosidase gene. Since these reporter genes encode enzyme proteins and detect their expression using an enzyme reaction, the detection sensitivity increases accordingly.
  • the reporter gene may be one that detects the signal of the product itself, such as a green fluorescent protein gene.
  • secretory alkaline phosphatase chloramphenicol acetyltransferase, and i3-galactosidase are preferable because their substrate products often emit visible light, so that enzyme activity can be easily detected.
  • the region that can hybridize with the region containing RBS may be a region that can hybridize with the RBS in this molecule or a region composed of RBS and the adjacent region.
  • “can hybridize” means to be able to hybridize under the conditions of use of this reagent. For example, after incubation at 37 ° C. in a prokaryotic cell extract and washing at 37 ° C. in the same solution. In addition, a positive hypritizing signal is observed.
  • this region and RBS are complementary, but mismatches may exist as long as hybridization is possible at the temperature at which the target nucleic acid detection method is performed. For example, if the temperature of this method is 37 ° C and there are 10 or more bases in the iridescence region. There can be a mismatch of more than / ⁇ .
  • the length of the region capable of hybridizing with RBS is preferably about 5 to 30 bases, more preferably about 8 to about 10 bases. Even if the target nucleic acid does not exist, this region and RBS are hybridized or single-stranded and are in equilibrium. If the length of this region is in the above range, such nonspecific double-strand dissociation that does not depend on the target nucleic acid hardly occurs.
  • the region that can hybridize with the target nucleic acid sequence has a loop structure in the absence of the target nucleic acid. The loop is extended by the formation of a double strand between this region and the target nucleic acid, thereby forming a stem.
  • target nucleic acid sequence examples include sequences in genes involved in human diseases when detection for genetic diagnosis of diseases is performed. In the case of detection for parent-child or forensic evaluation, sequences near genetic markers can be mentioned. In addition, when identifying pathogenic microorganisms that have infected humans or detecting foods to detect microbial contamination, chromosome sequences unique to those microorganisms can be mentioned.
  • the region that can hybridize with the target nucleic acid sequence should be hybridized to all or part of the target nucleic acid sequence. Above all, it is preferable that the region is complementary to the target nucleic acid sequence, so that even a single base mismatch can be detected. It may be complementary.
  • the length is preferably about 5 to 60 bases, more preferably about 14 to 20 bases. As described above, this region takes a loop structure in the absence of the target nucleic acid. However, if the length of the region that can hybridize with the target nucleic acid sequence is within the above range, double-stranded formation with the target nucleic acid occurs. By extending the loop, the double-stranded state of RBS can be easily eliminated, and the detection sensitivity of mismatches with the target nucleic acid is increased.
  • the ratio of the number of bases in the region capable of hybridizing with the target nucleic acid to the number of bases in the region containing RBS is preferably about 1 to 10 and more preferably about 2 to 5.
  • the stem can be easily opened by binding to the loop portion of the target nucleic acid, and the mismatch detection sensitivity is high when the length of the region that can hybridize with the target nucleic acid sequence is appropriate.
  • the region capable of hybridizing with the target nucleic acid sequence may be adjacent to the RBS, and an arbitrary sequence of about! To 5 bases may exist between them. Similarly, the region that can be hybridized with the target nucleic acid sequence may be adjacent to the region that can hybridize with the region containing RBS, or an arbitrary sequence of about 1 to 5 bases may exist between these regions. [0078]
  • the ribosome binding region, the start codon, and the reporter protein are encoded in this order from the upstream.
  • a reagent comprising a region that can be hybridized with a region containing a start codon via a region that can hybridize with a target nucleic acid sequence further upstream of the ribosome binding region.
  • the presence of the target nucleic acid makes the initiation codon strength in a double-stranded state, allowing binding of factors necessary for translation initiation, and translation is initiated.
  • the region that can hybridize with the target nucleic acid and the region that can hybridize with the start codon may be adjacent to each other, or an arbitrary sequence of about! To 5 bases may exist between them.
  • Other configurations are the same as those of the reagent having a stem including a ribosome binding region.
  • the upper limit of the size of the first reagent molecule of the present invention is not particularly limited as long as it can be translated into a reporter protein using a cell extract, but is usually 1000 ⁇
  • This reagent may contain a region that functions as a ribozyme that cleaves its own RNA strand when hybridized with a target nucleic acid.
  • the self-cleaving position may be a position that initiates translation of the reporter gene by cleaving RNA, but typically includes a position within a region capable of hybridizing with the target nucleic acid sequence.
  • the region that can hybridize with the target nucleic acid sequence is RNA, and this region functions as a ribozyme.
  • Such RNA includes, for example, a self-cleaving hammer-head type ribozyme having a region capable of hybridizing with a target nucleic acid sequence as a site for binding of a nucleic acid sequence to a hairpin-type ribozyme.
  • the second gene detection reagent of the present invention is a reagent containing DNA that can be transcribed into the first reagent described above and composed of RNA.
  • This DNA is usually double-stranded DNA.
  • This DNA should have a promoter region necessary for transcription upstream of the region that can hybridize with the region containing RBS.
  • the force S for which a plasmid containing a reporter gene is commercially available usually includes a promoter region, a ribosome binding region, an initiation codon, and a reporter gene. Therefore, a DNA sequence that can be transcribed into a region that can hybridize with the region containing RBS or the start codon and a region that can hybridize with the target nucleic acid sequence should be inserted between the promoter region and the ribosome binding region of this commercially available reporter plasmid. Les. This sequence can be chemically synthesized.
  • the second reagent of the present invention contains DNA that is difficult to be decomposed, it is a reagent with good storage stability.
  • the gene detection kit of the present invention is a kit provided with the gene detection reagent of the present invention described above.
  • a prokaryotic cell extract may be provided. Usually, since a factor necessary for transcription and translation is contained in a test sample, translation into a reporter protein, or transcription and translation is performed by this cell extract. If the ribosome binding region functions in eukaryotic cells or is derived from a virus, use a eukaryotic cell extract.
  • the cell extract may be prepared by the Zubay method (Zubay, G. Ann. Rev. Genet. 1978, 7, 267).
  • the kit of the present invention may further comprise an RNase having an activity of specifically cleaving RNA hybridized with DNA.
  • This RNase is preferably one that cleaves RNA in a region where DNA and RNA are completely complementary.
  • RNaseH has a very high mismatch recognition ability, so it can reliably detect single nucleotide polymorphisms.
  • This RNase is preferably an endonuclease, whereby the reagent RNA hybridized with the target nucleic acid can be efficiently cleaved and the target nucleic acid can be separated from the reagent RNA.
  • An example of such an RNase is RNaseH.
  • a test sample and the gene detection reagent of the present invention are mixed. In the test sample by comparing the expression level of the reporter protein from the gene detection reagent with the expression level of the reporter protein from the gene detection reagent of the present invention in the absence of the test sample. And a second step of determining the presence or absence of the target nucleic acid.
  • the reporter protein may be expressed in the presence of a prokaryotic cell extract.
  • test samples include, but are not limited to, collected cells such as mucosal cells in the oral cavity, blood, saliva, hair, and the like. Foods that are suspected of bacterial infection can also be used.
  • the test sample may be used as it is when the nucleic acid is exposed in the sample, but it is usually sufficient to use the cells by crushing or lysing the cells according to a conventional method.
  • the sensitivity is further improved if the target nucleic acid sequence is amplified by PCR with respect to the cell lysate or cell lysate.
  • the amount of the reagent of the present invention to be used should be about 1 to 10 times in molar ratio with respect to the test sample when the reagent contains RNA. It should be about 0.1 times. In addition, the amount of cell extract used may be about 2.5 to 10 / iL per test sample.
  • RNA-degrading enzyme that specifically degrades RNA hybridized with DNA can be mixed. Since this RNase does not degrade single-stranded RNA before hybridization, the mixing order thereof is not particularly limited. For example, a mixture of RNase and a gene detection reagent may be added to a test sample. Good.
  • the method of the present invention is a single-nucleotide polymorphism detection method.
  • the region that can hybridize with the target nucleic acid sequence in the reagent for gene detection has a sequence complementary to the wild type sequence of the target nucleic acid sequence or the predicted single nucleotide variant sequence, the displacement force, and the like. Let's do it.
  • reporter protein expression may be detected by a method according to the type. The expression of these proteins can be detected and measured using the following commercially available kits.
  • the expression of noluciferase is detected using a luminometer, a liquid scintillation counter, a top counter, or the like by adding luciferin (for example, manufactured by Toyo Ink) as a luminescent substrate to the cell lysate and luminescence due to decomposition of the substrate.
  • luciferin for example, manufactured by Toyo Ink
  • alkaline phosphatase can be detected and measured using, for example, L x Mi_Phos530 (manufactured by Wako Pure Chemical Industries, Ltd.).
  • chloramphenicol acetyltransferase can be detected and measured using FAST CAT Chrolam phenicol Acetyltransferase Assay Kit (manufactured by Wako Pure Chemical Industries, Ltd.).
  • ⁇ -galactosidase expression can be detected and measured using Aurora Gal-XE (Wako Pure Chemical Industries, Ltd.)
  • the expression level of the reporter protein may be compared between when the test sample is not present, that is, when the reagent of the present invention is incubated under the same conditions and when the test sample is present. .
  • the amount of protein expression can be compared directly by visual observation.
  • the protein expression level in each case can be measured and compared.
  • the criteria for measuring the protein expression level in each case are not limited thereto. For example, if the protein expression level is improved 3 times or more due to the presence of the test sample, the target nucleic acid sequence in the test sample is determined. Can be determined to exist.
  • a first use of the present invention is a nucleic acid comprising a region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, wherein the higher-order structural change is caused by hybridization with the target nucleic acid.
  • a second use of the present invention is RNA comprising a region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, and is highly induced by hybridization with the target nucleic acid.
  • the next structural change is the use of DNA as a gene detection reagent that can be transcribed into RNA that initiates translation into a reporter protein.
  • Plasmid pGL3 containing the firefly luciferase gene was purchased from Promega. Forward primer containing 3 'terminal partial region complementary to the target and SD sequence (5' _d (GGT CTG AAG GTT TAT TAG AAG GAG ATA TAC CAA TGG AAG ACG CCA AAA ACA TA) -3 ,: SEQ ID NO: 2 ) 5 pmol and reverse primer (5'_d (TATTCTATTACAC GGC GATCTTTCC G) -3 ': SEQ ID NO: 3) Using a 25 ⁇ 1 reaction mixture containing 5 pmol, the plasmid pGL3 was used as a saddle. The first PCR was performed.
  • the first round of PCR included 5 ng of pGL3 vector, 1.25 U of Pfu Ultra HF DNA polymerase (Stratagene), 5 nmol of each dNTPs (Toyobo), and 2.5 ⁇ L of 10 X Pfu Ultra HF reaction. A buffer was used. PCR conditions were 95 ° C for 3 minutes (95 ° C for 45 seconds, 54 ° C for 45 seconds, 72 ° C for 1 minute) for 30 cycles and 72 ° C for 10 minutes.
  • SEQ ID NO: 6 The base sequence of this DNA is shown in SEQ ID NO: 6.
  • base numbers 1 to 22 are T7-promoter regions, and 6 bases of base numbers 73 to 77 are SD sequences (ribosomes).
  • a luciferase gene whose base numbers 86 to 1722 start from the start codon.
  • Base numbers 54 to 69 are sequences that give a complementary sequence to CCR5, which is the target sequence, when transcribed into mRNA.
  • MB-controlled luciferase mRNA force was obtained by ST7 run-off transcription using the T7 MEGAshortscript kit (Ambion). Briefly, ⁇ 7 transcription reaction mixture (10 ⁇ L) containing 3 ⁇ L of the second PCR solution of vertical DNA was incubated at 37 ° C for 120 minutes. 1 U DNase I was added to the reaction mixture and the mixture was incubated for an additional 15 minutes.
  • mRNA was purified using the RNeasy MinElute Cleanup kit (Qiagen). The concentration of mRNA was determined by measuring the absorbance at 260 nm.
  • FIG. 1 The structure of the thus obtained MB-luciferase mRNA is shown in FIG.
  • This RNA has a reporter gene corresponding portion and a regulatory hairpin structure upstream thereof.
  • the hairpin structure has an 8 base long stem and a 19 base long loop.
  • the stem contains 6 bases of RBS.
  • the 18 bases including the loop are complementary to the 620th to 635th base sequences of the human CC chemokine receptor 5 (CCR5) gene (5, -AATAAACCTTCAGACC-3 ': SEQ ID NO: 7).
  • CCR5 human CC chemokine receptor 5
  • CCR5 is an HIV-1 core receptor, and its sequence diversity is considered a haplotype marker for promoting / delaying HIV-1 infection. Therefore, the selectivity of this sequence is important.
  • Reconstructed E. coli translation solution (T7) containing 1.8 pmol of the truncated MB-luciferase mRNA obtained in Example 1 in the presence or absence of the target CCR5 oligodeoxynucleotide (18 pmol) —Transcription / translation coupled, Pure System Classic 1, Post Genome Laboratories). A total volume of 10 ⁇ L of the reaction mixture was incubated at 37 ° C. for 60 minutes.
  • an oligonucleotide (5'-CCGTAAATAAACCTTCAGACCAGAGA-3 ': SEQ ID NO: 8) containing the 620th to 635th base sequences of the CCR5 gene was used as a full-matched oligonucleotide.
  • SEQ ID NO: 8 Those obtained by mutating C of base number 13 to T by 1 base and those obtained by mutating C of base number 13 by 1 base to A were used as 1-base mismatched oligonucleotides, respectively. Further, a C-mutated C at base number 13 and a T-mutated base T at base number 14 were used as a 2-base mismatched oligonucleotide.
  • FIG. 2 is a graph showing the chemiluminescence intensity in the presence of a fully-matched oligodeoxynucleotide and a mismatched oligodeoxynucleotide as a relative value to the chemiluminescence intensity in the absence of these targets.
  • Example 2 The same procedure as in Example 2 was performed, except that 0.2 pmol of MB-luciferase-expressing dsDNA cage was used in place of 8 pmol of MB-luciferase mRNA.
  • Fig. 4 shows 102.5 ⁇ L of each reaction mixture transferred to a 250 ⁇ L Eppendorf tube and its chemiluminescence image measured by Versadoc3000. Figure 4 shows that even a single base mutation in a gene can be clearly identified by visual inspection.
  • the efficiency of the transcription reaction was determined by using a diluted mRNA solution (0, 20, 40, 60, 80, 100%) of transcription mRNA in the presence of CCR5 full-matched oligonucleotide as an internal standard. This was done by comparing the amount of transcription in the presence.
  • Fig. 5 shows the chemiluminescence images of each reaction mixture measured by ATTO densitograph. In the presence of the full-matched oligonucleotide, the same emission intensity as that in the absence of the target nucleotide was observed.
  • Example 2 chemiluminescence intensity was measured by changing the amount of CCR5 full-matched oligonucleotides used as targets at 0-22 pmo (FIG. 6). At about 7 pmol of CCR5 full-matched oligonucleotide, the chemiluminescence intensity is slightly saturated, but at lower concentrations, the target amount and luminescence intensity are almost proportional. In view of this force and linearity, it can be seen that the present luciferase expression type can be suitably used for detection and quantification of the target nucleic acid sequence.
  • Example 6 (Combined use of DNA degrading enzymes)
  • luciferase mRNA transcription was obtained in the same manner as in Example 1 except that the plasmid pBESTluc (Promega) was in the form of a cage.
  • the luciferase mRNA transcribed from this double-stranded DNA is complementary to the 620th to 637th base sequences of CCR5 (5'-AATAAACCTTCAGACCAG-3 ': SEQ ID NO: 9) as a region capable of hybridizing with the target nucleic acid sequence.
  • CCR5 5'-AATAAACCTTCAGACCAG-3 ': SEQ ID NO: 9
  • Have Others are the same as the double-stranded DNA strength obtained in Example 1 and the luciferase mRNA obtained.
  • Reverse primer (TAT TCA TTA CAA TTT GGA CTT TCC GCC) —3: ⁇ ⁇ column number 10)
  • Reverse primer (5, — d (TAT TCA TTA CAA TTT GGA CTT TCC GCC) — 3, ⁇ ⁇ column number 10)
  • the 1 ⁇ 8 pmol MB-luciferase mRNA thus obtained was reconstituted in the presence or absence of the target CCR5 oligodeoxynucleotide (1.8 pmol) in E. coli translation solution ( T7—Transcription / Translation Coupled, Pure System Classic 1, Post Genome Laboratories).
  • E. coli translation solution T7—Transcription / Translation Coupled, Pure System Classic 1, Post Genome Laboratories.
  • the reaction mixture with a total volume of 10 ⁇ L was incubated at 37 ° C. for 60 minutes.
  • the target nucleic acid is a DNA having the 620th to 635th base sequences of the CCR5 gene.
  • Ligonucleotide (5, -AATAAACCTTCAGACC-3 ′: SEQ ID NO: 1 1) was used as a full-match oligodeoxynucleotide. Further, in SEQ ID NO: 11, the one obtained by mutating C of base number 8 to T by 1 base was used as a 1 base mismatch oligodeoxynucleotide.
  • FIG. Figure 7 shows the chemiluminescence intensity in the presence of full-matched oligonucleotides and single-base mismatched oligonucleotides, relative to the chemiluminescence intensity in the absence of target and RNaseH. It is a represented graph. Lanes! To 3 are the results in the absence of RNaseH, and lanes 4 to 6 are the results in the presence of RNaseH.
  • the single base mismatch used here is due to GT base pairs, which are relatively stable "fluctuating base pairs". Since the region complementary to the target nucleotide sequence in the truncated MB-luciferase mRNA is as short as 16 mer, it is difficult to distinguish between full match oligonucleotides and GT mismatch oligonucleotides without using RNaseH (lane 2, 3) By using RNa seH, it is clear that full-matched oligonucleotides and GT-mismatched oligonucleotides can be clearly distinguished (lanes 5 and 6). Since GT1 base mismatch can be detected, other single-base mismatches can be reliably detected.
  • an oligonucleotide (5'-CCGTAAATAAACCTTCAGACCAGAGA-3 ': SEQ ID NO: 8) containing the 620th to 637th nucleotide sequences of the CCR5 gene was used as a full-matched oligonucleotide.
  • Lanes 1 and 2 are the results in the presence of RNaseH
  • lanes 3 and 4 are the results in the absence of RNaseH. Even when the number of targets was very small, by using RNase e, very strong chemiluminescence was observed compared to the case where no target was present. It can be seen that transcription and translation of noreciferase were detected with a very small amount of target.
  • MB-controlled dsDNA for 3-galactosidase mRNA transcription was obtained in the same manner as Example 1 except that the following PCR primers were used.
  • the ⁇ -galactosidase mRNA transcribed from this double-stranded DNA has an mRNA encoding i3-galactosidase in place of the mRNA encoding luciferase.
  • a region that can be hybridized with the target nucleic acid sequence it has a sequence complementary to the 620th to 637th base sequences of CCR5 (5′—AATAA ACCTTCAGACCAG—3 ′: SEQ ID NO: 9).
  • Others are the same as the double-stranded DNA strength obtained in Example 1 and the obtained luciferase mRNA.
  • Reverse primer (5'_d (GGA TTA GTT ATT CAT TAT TTT TGA CAC CAG AC C AAO-3 ': SEQ ID NO: 13)
  • Reverse primer (5, _d (GGA TTA GTT ATT CAT TAT TTT TGA CAC CAG A
  • an oligonucleotide (5'-CCGTAAATAAACCTTCAGACCAGAGA-3 ': SEQ ID NO: 8) containing the 620th to 637th base sequences of the CCR5 gene was used as a full-matched oligonucleotide.
  • Fig. 9 The results are shown in Fig. 9 ( ⁇ ). Lanes 1 and 2 are the results in the absence of RNaseH, and lanes 3 and 4 are the results in the presence of RNaseH. In the presence of a full-match target, a stronger absorption at 405 nm due to the formation of nitrophenol was observed compared to the absence of the target. In addition, the use of RNaseH made it clearer from the case where no target was present.
  • Figure 9 (B) shows the color development by ⁇ -galatatosidase.
  • 2 and 3 are when RNaseH is used, 2 is when the target is not present, and 3 is when the full-match target is present.
  • 4 and 5 are when RNaseH is not used, and 4 is the target If not, 5 is when a full-match target is present.
  • 1 is the same as 4. 1 and 2 were transparent, but 3 was strongly yellow. 4 was transparent but 5 was colored yellow.
  • strong color development was observed due to the presence of the full-match target compared to the case where the target did not exist.
  • the use of RNaseH made it more distinct from the case where no target was present. Since the reaction product nitrophenol absorbs in the visible region, the target can be detected visually without using a special device if the j3_galactosidase gene is used as the reporter gene.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

It is intended to provide a gene detection reagent which comprises a region that can be hybridized to a target nucleotide sequence, a ribosome binding region, a start codon, and a region encoding a reporter protein characterized in that a conformational change is induced by being hybridized to a target nucleic acid and translation to the reporter protein is initiated. The target nucleic acid in a test sample is detected by mixing the test sample and the gene detection reagent and comparing the expression level of the reporter protein with the case where the test sample is not present.

Description

明 細 書  Specification

遺伝子検出用試薬及びその利用  Gene detection reagent and use thereof

技術分野  Technical field

[0001] 本発明は、外来遺伝子の存在や遺伝子の構造異常の検査に用いられる遺伝子検 出用試薬、及びキット、並びに遺伝子検出方法に関する。  [0001] The present invention relates to a gene detection reagent, kit, and gene detection method for use in examining the presence of a foreign gene or structural abnormality of a gene.

背景技術  Background art

[0002] 遺伝子検査は、 自己に存在しない外来遺伝子の存在を検査するものと、遺伝子の 構造異常を解析するものとに分けられる。外来遺伝子の存在を検査する場合として、 培養困難な微生物の同定検査、抗生物質加療中や感染初期の病原微生物の検出 などが挙げられる。また、遺伝子構造異常の検査として、遺伝病の確定診断のため の検査や遺伝病の予測検査、表現型には影響しなレ、DNA多型の検査 (親子鑑定 や法医学鑑定)などが挙げられる。  [0002] Genetic testing can be divided into those that examine the presence of foreign genes that do not exist in the self and those that analyze genetic structural abnormalities. Examples of testing for the presence of foreign genes include identification of microorganisms that are difficult to culture and detection of pathogenic microorganisms during antibiotic treatment and early infection. Examples of genetic structural abnormality tests include tests for definitive diagnosis of genetic diseases, prediction tests for genetic diseases, tests that do not affect phenotype, and DNA polymorphism tests (parent-child test and forensic test). .

[0003] 従来は、 目的遺伝子を増幅できる PCRプライマーを用いて被験試料について PCR を行い、 PCR産物をシークェンスする方法により、その遺伝子の存在や突然変異な どを検出していた。  [0003] Conventionally, PCR was performed on a test sample using a PCR primer capable of amplifying the target gene, and the presence or mutation of the gene was detected by a method of sequencing the PCR product.

[0004] 近年、細胞から遺伝子を抽出することなぐ細胞そのままの状態で遺伝子診断する ことができる試薬が提案されており、その代表例としてモレキュラービーコン (molecula r beacon)が挙げられる。このような試薬として、例えば、標的配列に相補的なループ 部分とその両端に存在するステム形成配列とからなるオリゴヌクレオチドであって、一 端に蛍光色素が結合し、他端に消光剤が結合したものが提案されている (非特許文 献 1)。  [0004] In recent years, a reagent capable of genetic diagnosis in the state of the cell without extracting the gene from the cell has been proposed, and a typical example thereof is a molecular beacon. As such a reagent, for example, an oligonucleotide comprising a loop portion complementary to a target sequence and stem-forming sequences present at both ends thereof, a fluorescent dye is bound to one end, and a quencher is bound to the other end. (Non-patent document 1).

この試薬は、標的核酸とハイブリダィズしていない状態で、光照射すると、両端の蛍 光色素と消光剤とが近接しているため、蛍光色素が発する蛍光が消光剤にエネルギ 一移動して蛍光を発せず、又は本来の蛍光とは異なる波長の光を発する。一方、標 的核酸がループ部分にハイブリダィズすると、ループ部分が 2本鎖になり剛直になる ためステム形成部分が解離する。これにより蛍光色素と消光剤とが離れるため、蛍光 物質本来の蛍光を発するようになる。従って、蛍光強度又は波長を検出することによ り、標的配列が存在するか否力を検出することができる。同文献のモレキュラービー コンによる標的配列の検出の様子を図 8に示す。 When this reagent is not hybridized with the target nucleic acid and irradiated with light, the fluorescent dye at both ends and the quencher are close to each other, so that the fluorescence emitted from the fluorescent dye transfers energy to the quencher to produce fluorescence. It does not emit light or emits light having a wavelength different from the original fluorescence. On the other hand, when the target nucleic acid is hybridized to the loop part, the loop part becomes double-stranded and rigid, so the stem forming part dissociates. As a result, the fluorescent dye and the quencher are separated, and the fluorescent substance inherent in the fluorescent material is emitted. Therefore, by detecting fluorescence intensity or wavelength. Thus, it is possible to detect whether or not the target sequence exists. Figure 8 shows how the target sequence is detected by the molecular beacon of this document.

[0005] しかし、この方法は、モレキュラービーコンに結合した蛍光色素が発する光をそのま ま検出するため、モレキュラービーコンを大量に使用しない限り検出感度が低い。  [0005] However, since this method detects the light emitted by the fluorescent dye bound to the molecular beacon as it is, the detection sensitivity is low unless a large amount of molecular beacons are used.

[0006] また、ループに標的核酸がハイブリダィズしたか否かを検出するために、蛍光色素 と消光剤との組み合わせにカ卩えて、 DNAザィム Zリボザィムを用いるモレキュラービ 一コンも提案されている(非特許文献 2)。図 9にこのモレキュラービーコンを用いた標 的核酸の検出方法を示す。 DNAザィムは、 2価金属イオンと結合した触媒活性を示 すループ部分の両側に標的核酸配列と相補的な 2つの領域を存在させたものであり 、この 2つの領域で標的核酸とハイブリダィズしてループ部分でそれを切断すると考 えられている。同文献に記載のモレキュラービーコンは、このような DNAザィムの一 方の標的結合領域を利用してステム—ループ構造を形成したものである。ループ部 分は標的核酸配列と相補的な配列を有する。  [0006] In order to detect whether or not the target nucleic acid has hybridized to the loop, a molecular bicon using a DNAzyme Z ribozyme has been proposed in addition to the combination of a fluorescent dye and a quencher ( Non-patent document 2). Figure 9 shows a method for detecting a target nucleic acid using this molecular beacon. The DNAzyme has two regions complementary to the target nucleic acid sequence on both sides of the loop portion that exhibits catalytic activity bound to a divalent metal ion, and hybridizes with the target nucleic acid in these two regions. It is thought to cut it at the loop. The molecular beacon described in this document has a stem-loop structure formed using such a target binding region of one of the DNAzymes. The loop portion has a sequence complementary to the target nucleic acid sequence.

[0007] この分子は、標的核酸の非存在下ではステム ループ構造を形成しているため、 DNAザィムがその標的核酸に結合できず、切断活性は発現しない。一方、ループ 領域に標的核酸がハイブリダィズするとループが開き、 DNAザィムがその標的核酸 に結合して切断活性が発現する。この切断活性を検出することにより、ループ部分に ハイブリダィズできる配列の存否を確認することができる。  [0007] Since this molecule forms a stem loop structure in the absence of the target nucleic acid, the DNAzyme cannot bind to the target nucleic acid, and the cleavage activity is not expressed. On the other hand, when the target nucleic acid is hybridized in the loop region, the loop opens, and the DNA zym binds to the target nucleic acid and the cleavage activity is expressed. By detecting this cleavage activity, the presence or absence of a sequence that can hybridize to the loop portion can be confirmed.

[0008] しかし、この方法も、モレキュラービーコン分子自体の切断活性を検出するため、検 出感度が低い。  However, this method also has low detection sensitivity because it detects the cleavage activity of the molecular beacon molecule itself.

[0009] 検出感度の高いモレキュラービーコンとして、非特許文献 3は、酵素に 1本鎖 DNA 断片を介してこの酵素に対するインヒビターを結合したものを報告している。このモレ キュラービーコンは、 1本鎖 DNA断片中に標的核酸配列と相補的な配列を含むもの であり、標的核酸が存在しないときは 1本鎖 DNA断片が柔軟であるためインヒビター が酵素の相互作用部位と結合しているが、標的核酸と DNA断片とがハイブリダィズ するとその部分が剛直になって伸びるためインヒビターが酵素から外れて酵素活性 が発現する。このモレキュラービーコンは、酵素による基質の変換を検出するため、 その分検出感度が高くなる。 [0010] しかし、この分子は、酵素タンパク質と核酸と低分子化合物という異質な物質を結 合させる手間を要し、コスト高になる。 [0009] As a molecular beacon with high detection sensitivity, Non-Patent Document 3 reports that an enzyme is bound to an inhibitor via a single-stranded DNA fragment. This molecular beacon contains a sequence complementary to the target nucleic acid sequence in the single-stranded DNA fragment, and when the target nucleic acid is not present, the single-stranded DNA fragment is flexible, so that the inhibitor interacts with the enzyme. Although it is bound to the site, when the target nucleic acid and the DNA fragment are hybridized, the part becomes rigid and extends, so that the inhibitor is removed from the enzyme and the enzyme activity is expressed. Since this molecular beacon detects the conversion of the substrate by the enzyme, the detection sensitivity is increased accordingly. [0010] However, this molecule requires time and labor to bind dissimilar substances such as enzyme proteins, nucleic acids, and low molecular weight compounds.

[0011] なお、特許文献 1は、リボレギュレーターと呼ばれる RNAを用いて特定遺伝子の翻 訳開始のオン'オフを調節して特定タンパク質の発現をコントロールし、生体内での そのタンパク質の機能を解明する方法を教えてレ、る。同文献のリボレギュレーターは 、リボソーム結合領域 (RBS)、開始コドン、及び緑色蛍光タンパク質コード領域を含 み、 RBSの上流に「シスリプレツシブ RNA」領域を有する mRNA分子である。  [0011] In addition, Patent Document 1 uses RNA called a riboregulator to control the on / off of translation start of a specific gene to control the expression of the specific protein and elucidate the function of the protein in vivo. Tell me how to do it. The riboregulator in this document is an mRNA molecule containing a ribosome binding region (RBS), an initiation codon, and a green fluorescent protein coding region, and having a “cis repressive RNA” region upstream of RBS.

シスリプレツシブ RNA領域は、分子内で RBSとハイブリダィズできる配列からなり、通 常はこの領域と RBSとがハイブリダィズしているため、リボソームは RBSに結合せず 緑色蛍光タンパク質への翻訳は行われない。さらに、シスリブレツシブ RNA領域に相 補的な領域を有する「トランスァクティべ一ティング RNA」をシスリブレツシブ RNAに ハイブリダィズさせることにより、シスリプレツシブ RNAと RBSとが解離し、緑色蛍光タ ンパク質への翻訳が行われる。  The cis-repressive RNA region consists of a sequence that can hybridize with RBS within the molecule. Normally, since this region and RBS are hybridized, the ribosome does not bind to RBS and is not translated into green fluorescent protein. Furthermore, cis-reactive RNA and RBS are dissociated by the “transactivating RNA” having a complementary region in the cis-reactive RNA region and hybridized to the cis-reactive RNA, which translates into a green fluorescent protein. Is called.

[0012] 同文献の方法では、トランスァクティべ一ティング RNAがリボソーム結合領域と略同 じ配列でなければならなレ、。従って、このリボレギュレーターは、任意の塩基配列の 存在を検出できるものではない。  [0012] According to the method of this document, the transactivating RNA must have the same sequence as the ribosome binding region. Therefore, this riboregulator cannot detect the presence of an arbitrary base sequence.

非特許文献 l : Tyagi, S.; Kramer, F. R. Nat. Biotechnol. 1996, 14, 303.  Non-patent literature l: Tyagi, S .; Kramer, F. R. Nat. Biotechnol. 1996, 14, 303.

非特許文献 2 : Stojanovic MN. et al. ChemBioChem 2001, 2, 411  Non-Patent Document 2: Stojanovic MN. Et al. ChemBioChem 2001, 2, 411

非特許文献 3 : Saghatelian, A. et al. J. Am. Chem. So 2003、 125、 344.  Non-Patent Document 3: Saghatelian, A. et al. J. Am. Chem. So 2003, 125, 344.

特許文献 1 : WO2004/046321号公報  Patent Document 1: WO2004 / 046321

発明の開示  Disclosure of the invention

発明が解決しょうとする課題  Problems to be solved by the invention

[0013] 本発明は、核酸からなる高感度な遺伝子検出用試薬、この試薬を含むキット、核酸 を用いて標的遺伝子の有無を高感度に検出することができる方法を提供することを 課題とする。 [0013] An object of the present invention is to provide a highly sensitive gene detection reagent comprising a nucleic acid, a kit including the reagent, and a method capable of detecting the presence or absence of a target gene with high sensitivity using a nucleic acid. .

課題を解決するための手段  Means for solving the problem

[0014] 上記課題を解決するために本発明者らは研究を重ね、以下の知見を得た。 [0014] In order to solve the above problems, the present inventors have conducted research and obtained the following knowledge.

(0 標的核酸配列とハイブリダィズできる領域、リボソーム結合領域、開始コドン、及 びレポータータンパク質をコードする領域を備え、標的核酸とそれに相補的な領域と のハイブリダィズにより誘起される高次構造変化がレポータータンパク質への翻訳を 開始させるような RNAは、レポータータンパク質の発現を検出することにより、標的核 酸を検出することができ、遺伝子検出用試薬として使用できる。 (0 Region that can hybridize with target nucleic acid sequence, ribosome binding region, start codon, and RNA that has a region that encodes a reporter protein, and whose conformational change induced by hybridization between the target nucleic acid and its complementary region initiates translation into the reporter protein, detects the expression of the reporter protein Therefore, the target nucleic acid can be detected and used as a gene detection reagent.

(ii) 例えば、上流より順に、リボソーム結合領域 (以下、「RBS」ということもある)、開 始コドン、及びレポータータンパク質をコードする領域を備え、リボソーム結合領域の 上流に、標的核酸配列とハイブリダィズできる領域 (A)を介して、リボソーム結合領域 を含む領域とハイブリダィズできる領域 (B)を備える RNAは、標的核酸の非存在下 では、領域(B)と RBSとがハイブリダィズして、領域 (A)をループとするループ—ステ ム構造を採る。また、標的核酸の存在下では、標的核酸と領域 (A)とがハイブリダィ ズすることによりこの領域が剛直になってループが伸び、その結果、 RBSと領域(B) とが解離する。これにより、 RBSにリボソームが結合できるようになり、レポーター遺伝 子の翻訳が開始される。  (ii) For example, a ribosome binding region (hereinafter also referred to as “RBS”), a start codon, and a region encoding a reporter protein are provided in order from upstream, and the target nucleic acid sequence is hybridized upstream of the ribosome binding region. In the absence of a target nucleic acid, an RNA comprising a region (B) that can hybridize with a region containing a ribosome binding region via a region (A) can be hybridized with the region (B) and RBS. ) Is a loop- stem structure. Further, in the presence of the target nucleic acid, the target nucleic acid and the region (A) are hybridized, so that this region becomes rigid and the loop extends, and as a result, the RBS and the region (B) are dissociated. This allows RBS to bind to RBS and initiates translation of the reporter gene.

[0015] この現象を利用して、レポーター遺伝子の発現の有無を検出することにより、被験 試料中の標的核酸の有無や一塩基多型を判定することができる。  [0015] By utilizing this phenomenon and detecting the presence or absence of expression of the reporter gene, the presence or absence of the target nucleic acid or the single nucleotide polymorphism in the test sample can be determined.

[0016] 本発明は上記知見に基づき完成されたものであり、以下の遺伝子検出用試薬、遺 伝子検出用キット、及び遺伝子検出方法を提供する。  [0016] The present invention has been completed based on the above findings, and provides the following gene detection reagents, gene detection kits, and gene detection methods.

[0017] 項 1. 標的核酸配列とハイブリダィズできる領域、リボソーム結合領域、開始コドン 、及びレポータータンパク質をコードする領域を備える遺伝子検出用試薬であって、 前記標的核酸とのハイブリダィズにより高次構造変化が誘起され、レポータータンパ ク質への翻訳が開始される遺伝子検出用試薬。  [0017] Item 1. A gene detection reagent comprising a region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, wherein higher-order structural changes are caused by hybridization with the target nucleic acid. A reagent for gene detection that is induced and begins to translate into a reporter protein.

[0018] 項 2. 少なくとも、リボソーム結合領域、開始コドン、及びレポータータンパク質をコ ードする領域力 ¾NAである項 1に記載の遺伝子検出用試薬。  [0018] Item 2. The gene detection reagent according to Item 1, which has at least a region strength NA that codes at least a ribosome binding region, an initiation codon, and a reporter protein.

[0019] 項 3. リボソーム結合領域にリボソームが結合できない状態にあり、標的核酸とハ イブリダィズできる領域と標的核酸とのハイブリダィズにより誘起される高次構造変化 カ^ボソーム結合領域へのリボソームの結合を可能にしてレポータータンパク質への 翻訳を開始させるものである項 2に記載の遺伝子検出用試薬。  [0019] Item 3. The ribosome cannot bind to the ribosome binding region, and the conformation change induced by hybridization between the target nucleic acid and the region that can hybridize with the target nucleic acid. Item 3. The gene detection reagent according to Item 2, which enables translation into a reporter protein.

[0020] 項 4. 上流より順に、リボソーム結合領域、開始コドン、及びレポータータンパク質 をコードする領域を備え、リボソーム結合領域のさらに上流に、標的核酸配列とハイ ブリダィズできる領域を介して、リボソーム結合領域を含む領域とハイブリダィズでき る領域を備えるものである項 3に記載の遺伝子検出用試薬。 [0020] Item 4. In order from upstream, ribosome binding region, start codon, and reporter protein The gene detection according to Item 3, further comprising a region capable of hybridizing with a region including the ribosome binding region via a region capable of hybridizing with the target nucleic acid sequence further upstream of the ribosome binding region. Reagent.

[0021] 項 5. リボソーム結合領域を含む領域とハイブリダィズできる領域の塩基数に対す る、標的核酸配列とハイブリダィズできる領域の塩基数の比率が 1〜: 10である項 4に 記載の遺伝子検出用試薬。 [0021] Item 5. The gene detection according to Item 4, wherein the ratio of the number of bases in the region hybridizable with the target nucleic acid sequence to the number of bases in the region hybridizable with the region including the ribosome binding region is 1 to 10 reagent.

[0022] 項 6. リボソーム結合領域を含む領域とハイブリダィズできる領域が 5〜30塩基か らなり、標的核酸配列とハイブリダィズできる領域が 5〜60塩基からなる項 4に記載の 遺伝子検出用試薬。 [0022] Item 6. The gene detection reagent according to Item 4, wherein a region capable of hybridizing with a region containing a ribosome binding region comprises 5 to 30 bases, and a region capable of hybridizing with a target nucleic acid sequence comprises 5 to 60 bases.

[0023] 項 7. 標的核酸配列とハイブリダィズできる領域が、標的核酸配列と相補的な領域 である項 1に記載の遺伝子検出用試薬。  [0023] Item 7. The gene detection reagent according to Item 1, wherein the region capable of hybridizing with the target nucleic acid sequence is a region complementary to the target nucleic acid sequence.

[0024] 項 8. 標的核酸とハイブリダィズした場合に自己切断するリボザィムとして機能する 領域を含むものである項 1に記載の遺伝子検出用試薬。 [0024] Item 8. The gene detection reagent according to Item 1, comprising a region that functions as a ribozyme that cleaves when hybridized with a target nucleic acid.

[0025] 項 9. レポータータンパク質が酵素である項 1に記載の遺伝子検出用試薬。 [0025] Item 9. The gene detection reagent according to Item 1, wherein the reporter protein is an enzyme.

[0026] 項 10. 前記酵素が可視光を発生する物質の生産に関与するものである項 9に記 載の遺伝子検出用試薬。 Item 10. The reagent for gene detection according to Item 9, wherein the enzyme is involved in the production of a substance that generates visible light.

[0027] 項 11. 標的核酸配列とハイブリダィズできる領域、リボソーム結合領域、開始コド ン、及びレポータータンパク質をコードする領域を備え、標的核酸とのハイブリダィズ により誘起される高次構造変化がレポータータンパク質への翻訳を開始させる RNA に転写され得る DNAを含む遺伝子検出用試薬。 [0027] Item 11. A region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, wherein a conformational change induced by hybridization with the target nucleic acid is induced in the reporter protein. A gene detection reagent containing DNA that can be transcribed into RNA that initiates translation.

[0028] 項 12. 前記 RNA力 S、リボソーム結合領域にリボソームが結合できない状態にありItem 12. The RNA force S is in a state where ribosome cannot bind to the ribosome binding region.

、標的核酸とハイブリダィズできる領域と標的核酸とのハイブリダィズにより誘起される 高次構造変化カ^ボソーム結合領域へのリボソームの結合を可能にしてレポータータ ンパク質への翻訳を開始させるものである項 11に記載の遺伝子検出用試薬。 Section 11, which enables the ribosome to bind to the higher-order structurally modified ribosome binding region induced by hybridization between the target nucleic acid and the target nucleic acid hybridizing region, thereby initiating translation into the reporter protein. The reagent for gene detection described in 1.

[0029] 項 13. 前記 RNAが、上流より順に、リボソーム結合領域、開始コドン、及びレポ一 タータンパク質をコードする領域を備え、リボソーム結合領域のさらに上流に、標的核 酸配列とハイブリダィズできる領域を介して、リボソーム結合領域を含む領域とハイブ リダィズできる領域を備えるものである項 12に記載の遺伝子検出用試薬。 [0030] 項 14. リボソーム結合領域を含む領域とハイブリダィズできる領域の塩基数に対 する、標的核酸配列とハイブリダィズできる領域の塩基数の比率が 1〜10である項 1[0029] Item 13. The RNA comprises a region encoding a ribosome binding region, an initiation codon, and a reporter protein in order from upstream, and a region capable of hybridizing with a target nucleic acid sequence further upstream of the ribosome binding region. Item 13. The reagent for gene detection according to Item 12, comprising a region containing a ribosome binding region and a region that can be hybridized. [0030] Item 14. The ratio of the number of bases in a region capable of hybridizing to a target nucleic acid sequence to the number of bases in a region capable of hybridizing with a region including a ribosome binding region is 1 to 10.

3に記載の遺伝子検出用試薬。 4. The gene detection reagent according to 3.

[0031] 項 15. リボソーム結合領域を含む領域とハイブリダィズできる領域が 5〜30塩基 力 なり、標的核酸配列とハイブリダィズできる領域が 5〜60塩基からなる項 13に記 載の遺伝子検出用試薬。 Item 15. The reagent for gene detection according to Item 13, wherein the region capable of hybridizing with the region including the ribosome binding region has a strength of 5 to 30 bases, and the region capable of hybridizing with the target nucleic acid sequence has 5 to 60 bases.

[0032] 項 16. 標的核酸配列とハイブリダィズできる領域が、標的核酸配列と相補的な領 域である項 11に記載の遺伝子検出用試薬。 [0032] Item 16. The gene detection reagent according to Item 11, wherein the region capable of hybridizing with the target nucleic acid sequence is a region complementary to the target nucleic acid sequence.

[0033] 項 17. 前記 RNAが、標的核酸とハイブリダィズした場合に自己切断するリボザィ ムとして機能する領域を含むものである項 11に記載の遺伝子検出用試薬。 [0033] Item 17. The reagent for gene detection according to Item 11, wherein the RNA includes a region that functions as a ribozyme that cleaves when hybridized with a target nucleic acid.

[0034] 項 18. レポータータンパク質が酵素である項 11に記載の遺伝子検出用試薬。 [0034] Item 18. The gene detection reagent according to Item 11, wherein the reporter protein is an enzyme.

[0035] 項 19. 前記酵素が可視光を発生する物質の生産に関与するものである項 18に 記載の遺伝子検出用試薬。 Item 19. The gene detection reagent according to Item 18, wherein the enzyme is involved in the production of a substance that generates visible light.

[0036] 項 20. 項 1に記載の遺伝子検出用試薬を備える遺伝子検出用キット。 [0036] Item 20. A gene detection kit comprising the gene detection reagent according to Item 1.

[0037] 項 21. さらに、原核細胞抽出液を備える項 20に記載の遺伝子検出用キット。 [0037] Item 21. The gene detection kit according to Item 20, further comprising a prokaryotic cell extract.

[0038] 項 22. さらに、 DNAとハイブリダィズした RNAを特異的に切断する RNA分解酵 素を備える項 20に記載の遺伝子検出用キット。 [0038] Item 22. The gene detection kit according to Item 20, further comprising an RNA degrading enzyme that specifically cleaves RNA hybridized with DNA.

[0039] 項 23. 項 11に記載の遺伝子検出用試薬を備える遺伝子検出用キット。 [0039] Item 23. A gene detection kit comprising the gene detection reagent according to Item 11.

[0040] 項 24. さらに、原核細胞抽出液を備える項 23に記載の遺伝子検出用キット。 [0040] Item 24. The gene detection kit according to Item 23, further comprising a prokaryotic cell extract.

[0041] 項 25. さらに、 DNAとハイブリダィズした RNAを特異的に切断する RNA分解酵 素を備える項 23に記載の遺伝子検出用キット。 [0041] Item 25. The gene detection kit according to Item 23, further comprising an RNA degrading enzyme that specifically cleaves RNA hybridized with DNA.

[0042] 項 26. 被験試料と項 1に記載の遺伝子検出用試薬とを混合する第 1工程と、遺伝 子検出用試薬からのレポータータンパク質の発現量を、被験試料の非存在下での項[0042] Item 26. First step of mixing the test sample with the gene detection reagent according to Item 1, and the expression level of the reporter protein from the gene detection reagent in the absence of the test sample.

1に記載の遺伝子検出用試薬からのレポータータンパク質の発現量と比較することに より、被験試料中の標的核酸の有無を判定する第 2工程とを含む遺伝子検出方法。 A gene detection method comprising a second step of determining the presence or absence of a target nucleic acid in a test sample by comparing the expression level of a reporter protein from the gene detection reagent according to 1.

[0043] 項 27. 遺伝子検出用試薬からのレポータータンパク質の発現を原核細胞抽出液 の存在下で行う項 26に記載の方法。 [0043] Item 27. The method according to Item 26, wherein the reporter protein is expressed from the gene detection reagent in the presence of a prokaryotic cell extract.

[0044] 項 28. 第 1工程において、被験試料と、項 1に記載の遺伝子検出用試薬と、 DN Aとハイブリダィズした RNAを特異的に切断する RNA分解酵素とを混合する工程を 含む項 26に記載の方法。 [0044] Item 28. In the first step, the test sample, the gene detection reagent according to Item 1, and DN Item 27. The method according to Item 26, comprising the step of mixing A with an RNase that specifically cleaves the hybridized RNA.

[0045] 項 29. 被験試料と項 11に記載の遺伝子検出用試薬とを混合する第 1工程と、遺 伝子検出用試薬からのレポータータンパク質の発現量を、被験試料の非存在下での 項 11に記載の遺伝子検出用試薬からのレポータータンパク質の発現量と比較するこ とにより、被験試料中の標的核酸の有無を判定する第 2工程とを含む遺伝子検出方 法。 [0045] Item 29. The first step of mixing the test sample with the gene detection reagent according to Item 11, and the expression level of the reporter protein from the gene detection reagent in the absence of the test sample. A gene detection method comprising a second step of determining the presence or absence of a target nucleic acid in a test sample by comparing with the expression level of a reporter protein from the gene detection reagent according to Item 11.

[0046] 項 30. 遺伝子検出用試薬からのレポータータンパク質の発現を原核細胞抽出液 の存在下で行う項 29に記載の方法。  [0046] Item 30. The method according to Item 29, wherein the reporter protein is expressed from the gene detection reagent in the presence of a prokaryotic cell extract.

[0047] 項 31. 第 1工程において、被験試料と、項 1に記載の遺伝子検出用試薬と、 DN[0047] Item 31. In the first step, the test sample, the gene detection reagent according to Item 1, and DN

Aとハイブリダィズした RNAを特異的に切断する RNA分解酵素とを混合する工程を 含む項 29に記載の方法。 Item 30. The method according to Item 29, comprising a step of mixing A with an RNase that specifically cleaves the hybridized RNA.

[0048] 項 32. 被験試料と、項 1に記載の遺伝子検出用試薬と、 DNAとハイブリダィズし た RNAを特異的に切断する RNA分解酵素とを混合する第 1工程と、遺伝子検出用 試薬からのレポータータンパク質の発現量を、被験試料の非存在下での項 1に記載 の遺伝子検出用試薬からのレポータータンパク質の発現量と比較することにより、被 験試料中の標的核酸の有無を判定する第 2工程とを含む 1塩基多型の検出方法。 [0048] Item 32. A first step of mixing a test sample, the gene detection reagent according to Item 1, and an RNase that specifically cleaves RNA hybridized with DNA, and a gene detection reagent The presence or absence of the target nucleic acid in the test sample is determined by comparing the expression level of the reporter protein with the expression level of the reporter protein from the gene detection reagent according to Item 1 in the absence of the test sample. A method for detecting a single nucleotide polymorphism comprising the second step.

[0049] 項 33. 被験試料と、項 11に記載の遺伝子検出用試薬と、 DNAとハイブリダィズし た RNAを特異的に切断する RNA分解酵素とを混合する第 1工程と、遺伝子検出用 試薬からのレポータータンパク質の発現量を、被験試料の非存在下での項 11に記 載の遺伝子検出用試薬からのレポータータンパク質の発現量と比較することにより、 被験試料中の標的核酸の有無を判定する第 2工程とを含む 1塩基多型の検出方法。 [0049] Item 33. A first step of mixing a test sample, the gene detection reagent according to Item 11, and an RNase that specifically cleaves RNA hybridized with DNA, and a gene detection reagent The presence or absence of the target nucleic acid in the test sample is determined by comparing the expression level of the reporter protein with the expression level of the reporter protein from the gene detection reagent described in Item 11 in the absence of the test sample. A method for detecting a single nucleotide polymorphism comprising the second step.

[0050] 項 34. 標的核酸配列とハイブリダィズできる領域、リボソーム結合領域、開始コド ン、及びレポータータンパク質をコードする領域を備える核酸であって、前記標的核 酸とのハイブリダィズにより高次構造変化が誘起され、レポータータンパク質への翻 訳が開始される核酸の遺伝子検出用試薬としての使用。  [0050] Item 34. A nucleic acid comprising a region capable of hybridizing with a target nucleic acid sequence, a ribosome-binding region, an initiation codon, and a region encoding a reporter protein, wherein a conformation change is induced by hybridization with the target nucleic acid. And use as a reagent for gene detection of a nucleic acid that begins translation into a reporter protein.

[0051] 項 35. 標的核酸配列とハイブリダィズできる領域、リボソーム結合領域、開始コド ン、及びレポータータンパク質をコードする領域を備える RNAであり、標的核酸との ハイブリダィズにより誘起される高次構造変化がレポータータンパク質への翻訳を開 始させる RNAに転写され得る DNAの遺伝子検出用試薬としての使用。 [0051] Item 35. RNA comprising a region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, Use as a reagent for gene detection of DNA that can be transcribed into RNA that initiates translation into a reporter protein by a conformational change induced by hybridisation.

発明の効果  The invention's effect

[0052] 本発明の第 1の試薬である RNAからなる遺伝子検出用試薬によれば、被験試料中 の標的核酸の存否が、レポータータンパク質をコードする RNAからレポータータンパ ク質への翻訳の有無として現れる。この翻訳により 1分子の RNAから例えば複数分 子のレポータータンパク質が生産可能になるため、蛍光等の検出シグナルを増幅で き、検出感度の向上を図ることができる。このため、本発明の試薬を用いる場合は、 被験試料中の核酸を PCRなどで予め増幅することを必ずしも要さず、細胞溶解液な どを直接被験試料として用いることができる。  [0052] According to the gene detection reagent comprising RNA, which is the first reagent of the present invention, the presence or absence of the target nucleic acid in the test sample is the presence or absence of translation from the RNA encoding the reporter protein into the reporter protein. appear. This translation makes it possible to produce, for example, a multi-molecule reporter protein from one molecule of RNA, so that detection signals such as fluorescence can be amplified and detection sensitivity can be improved. Therefore, when the reagent of the present invention is used, it is not always necessary to amplify the nucleic acid in the test sample in advance by PCR or the like, and a cell lysate or the like can be directly used as the test sample.

[0053] また、本発明の第 2の試薬である DNAからなる遺伝子検出用試薬によれば、 DNA 力 RNAへの転写課程が加わり、 DNA1分子から複数分子の RNAが生成する。ま た、 DNAは非常に安定であるため、試薬として使い易いものとなる。  [0053] In addition, according to the gene detection reagent comprising DNA, which is the second reagent of the present invention, a transcription process to DNA force RNA is added, and multiple molecules of RNA are generated from one DNA molecule. Also, since DNA is very stable, it is easy to use as a reagent.

[0054] さらに、レポータータンパク質として、例えばルシフェラーゼゃ β ガラクトシダーゼ のような酵素を用いる場合は、 1分子の酵素から複数分子の基質が変換されるため、 より一層検出感度が高くなる。  [0054] Further, when an enzyme such as luciferase or β-galactosidase is used as the reporter protein, the detection sensitivity is further enhanced because a plurality of substrates are converted from one molecule of enzyme.

[0055] また、本発明の遺伝子検出用試薬とともに、 DNAとハイブリダィズした DNA—RN Α2本鎖中の RNAを特異的に切断する RNA分解酵素を用レ、る場合は、本発明の第 1の試薬である RNA又は第 2の試薬である DNAの転写産物 RNAと標的核酸(通常 は DNA)とがハイブリダィズすると、試薬側の RNA鎖が切断され、標的核酸から乖 離する。標的核酸はさらに別の RNA分子と結合することができ、同様に酵素の作用 で試薬 RNAの切断、及び標的核酸からの乖離のサイクルを形成する。このようにし て、 1分子の標的核酸が次々に本発明試薬とハイブリダィズすることにより、レポータ 一遺伝子の発現を増幅させることができる。このため、検出感度が一層向上し、標的 核酸がフェムトモルオーダーしか存在しない場合でも、標的核酸を PCR等で増幅さ せることなく遺伝子検出を行うことができる。  [0055] In addition, in the case of using an RNase that specifically cleaves RNA in a DNA-RNΑ double strand hybridized with DNA together with the gene detection reagent of the present invention, the first of the present invention When the RNA of the reagent or the transcription product RNA of the second reagent RNA and the target nucleic acid (usually DNA) are hybridized, the RNA strand on the reagent side is cleaved and separated from the target nucleic acid. The target nucleic acid can further bind to another RNA molecule, and similarly forms a cycle of cleavage of the reagent RNA and detachment from the target nucleic acid by the action of an enzyme. In this way, the expression of one reporter gene can be amplified by successively hybridizing one molecule of the target nucleic acid with the reagent of the present invention. For this reason, detection sensitivity is further improved, and even when the target nucleic acid exists only in femtomolar order, gene detection can be performed without amplifying the target nucleic acid by PCR or the like.

[0056] ここで、本発明の試薬にぉレ、ては、標的核酸配列とハイブリダィズできる領域が長く なるほど塩基配列選択性が低下し、即ちミスマッチが存在する場合に検出可能なそ のミスマッチ塩基数が少なくなる。一方、試薬 RNA分子において、標的核酸配列と ハイブリダィズできる領域を短くする場合は、高次構造変化を引き起こす力が弱くな るため、その分、ノ、イブリダィズによる高次構造変化を起こし易い構造にする必要が ある。この場合は、非特異的な RNA分子の高次構造変化が生じ易くなる。従って、 標的核酸配列とハイブリダィズできる領域を短くする場合は、ハイブリダィズによる高 次構造変化を起こし易くするために、例えば、リボソーム結合領域を含む領域とハイ ブリダィズできる領域の長さをその分短くする必要がある。この場合、非特異的にリボ ソーム力 Sリボソーム結合領域と結合してレポーター遺伝子の発現が生じ易くなる。 [0056] Here, the base sequence selectivity decreases as the region that can be hybridized with the target nucleic acid sequence becomes longer, that is, it can be detected when there is a mismatch. The number of mismatched bases decreases. On the other hand, when shortening the region that can hybridize with the target nucleic acid sequence in the reagent RNA molecule, the force that causes higher-order structural changes is weakened. There is a need. In this case, higher-order structural changes of non-specific RNA molecules are likely to occur. Therefore, when shortening the region that can hybridize with the target nucleic acid sequence, it is necessary to shorten the length of the region that includes the ribosome binding region and the region that can be hybridized, for example, in order to facilitate higher-order structural changes due to hybridization. There is. In this case, the expression of the reporter gene is likely to occur due to nonspecific binding to the ribosomal force S ribosome binding region.

[0057] このような状況の下で、本発明の試薬と共に、 DNA—RNA2本鎖の RNAを特異 的に切断する RNA分解酵素を用いる場合は、標的核酸が試薬 RNA分子と結合す ると RNA分解酵素がこの RNA分子を切断して強制的に高次構造変化を起こさせる 。即ち、リボソーム結合領域や開始コドンがそれに相補的な配列とハイブリダィズして レ、る状態が解消される。このため、試薬 RNA分子の標的核酸配列とハイブリダィズ できる領域の長さが短ぐかつ高次構造変化を起こし難い分子構造としても(例えばリ ポソーム結合領域を含む領域とハイブリダィズできる領域を長くしても)、ハイブリダィ ズにより一層確実に高次構造変化が起こるようになる。これにより、標的核酸と標的核 酸とハイブリダィズできる領域との間の 1塩基のミスマッチでも一層確実に検出できる ようになり、即ち 1塩基多型の検出が可能になる。また、完全にマッチする塩基対の みを切断するという RNA分解酵素の性質によっても、 1塩基ミスマッチの選択性が上 昇する。 [0057] Under such circumstances, when an RNase that specifically cleaves DNA-RNA double-stranded RNA is used together with the reagent of the present invention, RNA that is bound when the target nucleic acid binds to the reagent RNA molecule. Degradative enzymes cleave this RNA molecule to force conformational changes. That is, the state in which the ribosome binding region and the start codon hybridize with a complementary sequence is eliminated. For this reason, even if the length of the region capable of hybridizing with the target nucleic acid sequence of the reagent RNA molecule is short and the molecular structure hardly undergoes a higher order structural change (for example, even if the region capable of hybridizing with the region including the liposome binding region is lengthened). ), Hybridization will ensure higher-order structural changes. As a result, even a single base mismatch between the target nucleic acid and the region capable of hybridizing with the target nucleic acid can be detected more reliably, that is, a single nucleotide polymorphism can be detected. The selectivity of single-base mismatch is also enhanced by the nature of RNase, which cleaves only perfectly matched base pairs.

[0058] また、試薬 RNA自体が、標的核酸とハイブリダィズした場合に自己切断する能力を 有するリボザィムである場合も、上記 RNA分解酵素を使用する場合と同様の効果が 得られる。  [0058] Also, when the reagent RNA itself is a ribozyme that has the ability to self-cleavage when hybridized with the target nucleic acid, the same effect as that obtained when the RNase is used can be obtained.

[0059] 本発明試薬を用いたこのような遺伝子検出は、「触媒的遺伝子検出」と称することが できる。  [0059] Such gene detection using the reagent of the present invention can be referred to as "catalytic gene detection".

[0060] また、本発明の遺伝子検出用試薬は、蛍光物質や酵素インヒビターのような合成化 合物を含まず、核酸のみから構成されるため、製造が簡単である。また、使用に当た り、細胞抽出液を用いるだけでよい。また、生体由来材料だけを用いて製造、及び使 用できるため、将来的な生体への適用可能性が広がる。 [0060] Further, the gene detection reagent of the present invention does not contain a synthetic compound such as a fluorescent substance or an enzyme inhibitor, and is composed only of nucleic acid, so that it is easy to manufacture. Moreover, it is only necessary to use the cell extract for use. It is also manufactured and used using only biological materials. Therefore, it can be applied to future living organisms.

図面の簡単な説明 Brief Description of Drawings

[図 1]実施例 1で構築した MB—ルシフェラーゼ mRNAの構造を示す図である。 FIG. 1 is a diagram showing the structure of MB-luciferase mRNA constructed in Example 1.

[図 2]MB—ルシフェラーゼ mRNAを錡型とした場合の、フルマツチオリゴデォキシヌ クレオチド、及びミスマッチオリゴデォキシヌクレオチドの存在下での化学発光強度を 、こられのターゲットが存在しない場合の化学発光強度に対する相対値で表したダラ フである。  [Fig. 2] Chemiluminescence intensity in the presence of flumati oligonucleotides and mismatched oligonucleotides when MB-luciferase mRNA is in the saddle type, in the absence of these targets It is a duff expressed as a relative value to the chemiluminescence intensity.

[図 3]MB ルシフェラーゼ発現 dsDNAを铸型とした場合の、フルマツチオリゴデォ キシヌクレオチド、及びミスマッチオリゴデォキシヌクレオチドの存在下での化学発光 強度を、これらのターゲットが存在しない場合の化学発光強度に対する相対値で表 したグラフである。  [Fig. 3] MB luciferase expression Chemiluminescence intensity in the presence of flumati oligonucleotide and mismatched oligodeoxynucleotide when dsDNA is in a saddle type, chemistry in the absence of these targets It is a graph expressed as a relative value with respect to emission intensity.

[図 4]MB ルシフェラーゼ発現 dsDNAを铸型とした場合の、フルマツチオリゴデォ キシヌクレオチド、及びミスマッチオリゴデォキシヌクレオチドの存在下での各反応混 合物の化学発光像を Versadoc3000で測定したものである。  [FIG. 4] Chemiluminescence images of each reaction mixture were measured with Versadoc3000 in the presence of flumati oligonucleotides and mismatched oligonucleotides when MB luciferase-expressed dsDNA was in a saddle type. Is.

[図 5]フルマッチオリゴデォキシヌクレオチドの存在下及びターゲットの非存在下で、 铸型 MB—ルシフェラーゼ DNAをリボソーム、及び tRNAを含まないセルフリー転写 /翻訳システムを用いて転写したときの蛍光像を ATTOデンシトグラフで測定したも のである。 [Fig. 5] Fluorescence image of MB-type MB-luciferase DNA transcribed using a cell-free transcription / translation system that does not contain ribosomes and tRNA in the presence of full-matched oligonucleotides and in the absence of target Was measured with an ATTO densitograph.

[図 6]ターゲット量に対する化学発光強度の関係を示すグラフである。  FIG. 6 is a graph showing the relationship of chemiluminescence intensity to target amount.

[図 7]MB—ルシフェラーゼ mRNAを錡型とした場合の、フルマツチオリゴデォキシヌ クレオチド、及び 1塩基 GTミスマッチオリゴデォキシヌクレオチドの存在下での化学 発光強度を、ターゲットが存在しない場合の化学発光強度に対する相対値で表した グラフである。また、 RNaseHの使用による効果を示すグラフである。  [Fig. 7] Chemoluminescence intensity in the presence of flumati oligonucleotide and 1-base GT mismatched oligonucleotide when MB-luciferase mRNA is in the saddle type, without target It is the graph represented with the relative value with respect to the chemiluminescence intensity of. Moreover, it is a graph which shows the effect by use of RNaseH.

[図 8]MB—ルシフェラーゼ mRNAを錡型とした場合の、フルマツチオリゴデォキシヌ クレオチドの存在下での化学発光強度を、ターゲットが存在しなレ、場合の化学発光 強度に対する相対値で表したグラフである。また、 RNaseHの使用による効果を示す グラフである。  [Fig. 8] The chemiluminescence intensity in the presence of flumatsu oligodeoxynucleotide when MB-luciferase mRNA is of the vertical type, relative to the chemiluminescence intensity in the absence of the target. It is the represented graph. Also, it is a graph showing the effect of using RNaseH.

[図 9]図(A)は、 MB— ガラクトシダーゼ dsRNAを铸型とした場合の、フルマツチ オリゴデォキシヌクレオチドの存在下でのニトロフエノールによる吸光度を、ターゲット が存在しない場合の吸光度に対する相対値で表したグラフである。また、 RNaseH の使用による効果を示すグラフである。図(B)は、 β ガラクトシダーゼ dsDNAを铸 型とした場合のニトロフヱノールによる発色を目視観察した結果である。 [Fig. 9] Fig. (A) shows the full-maturity of MB-galactosidase dsRNA in the vertical type. It is the graph which represented the light absorbency by nitrophenol in presence of an oligodeoxynucleotide with the relative value with respect to the light absorbency in case a target does not exist. Moreover, it is a graph which shows the effect by use of RNaseH. Fig. (B) shows the result of visual observation of coloration by nitrophenol when β-galactosidase dsDNA is in the form of a cage.

[図 10]従来のモレキュラービーコンの 1例を用いた遺伝子検出を説明する図である。  FIG. 10 is a diagram for explaining gene detection using an example of a conventional molecular beacon.

[図 11]従来のモレキュラービーコンの他の例を用いた遺伝子検出を説明する図であ る。  FIG. 11 is a diagram for explaining gene detection using another example of a conventional molecular beacon.

発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION

[0062] 以下、本発明を詳細に説明する。 [0062] Hereinafter, the present invention will be described in detail.

m¾云チネ金 言式  m¾ 云 chine gold expression

RNAからなる試薬  Reagent consisting of RNA

本発明の第 1の遺伝子検出用試薬は、標的核酸配列とハイブリダィズできる領域、 リボソーム結合領域、開始コドン、及びレポータータンパク質をコードする領域を備え 、標的核酸とのハイブリダィズにより誘起される高次構造変化がレポータータンパク 質への翻訳を開始させる試薬である。  The first gene detection reagent of the present invention comprises a region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, and a conformational change induced by hybridization with the target nucleic acid. Is a reagent that initiates translation into a reporter protein.

[0063] この試薬は、少なくともリボソーム結合領域、開始コドン、及びレポータータンパク質 をコードする領域が RNA力、らなっていればよレ、。それ以外の部分は、 RNA、 DNA、 又は人工核酸等のいずれの核酸配列であってもよレ、。人工核酸としては、ペプチド 核酸 (PNA;P印 tide Nucleic Acid), LNA(Locked Nucleic Acid)等が挙げられる。  [0063] This reagent should have at least a ribosome-binding region, an initiation codon, and a region encoding a reporter protein having RNA power. The other part may be any nucleic acid sequence such as RNA, DNA, or artificial nucleic acid. Examples of the artificial nucleic acid include peptide nucleic acid (PNA; P-marked tide Nucleic Acid), LNA (Locked Nucleic Acid) and the like.

[0064] この試薬の構造は、標的核酸とハイブリダィズできる領域に標的核酸が結合するこ とにより、翻訳開始に必要な因子がこの試薬に結合できるようになる構造であれば良 レ、。このような構造として、標的核酸にハイブリダィズできる領域をループとし、その両 側に存在する 2領域が塩基対形成によりステムを形成しているようなヘアピン構造が 挙げられる。ステムを形成する 2領域としては、例えば、リボソーム結合領域及びそれ を含む領域とハイブリダィズできる領域、開始コドン及びそれを含む領域とハイブリダ ィズできる領域などが挙げられる。  [0064] The structure of the reagent is not particularly limited as long as the target nucleic acid binds to a region capable of hybridizing with the target nucleic acid, so that a factor necessary for translation initiation can be bound to the reagent. Examples of such a structure include a hairpin structure in which a region capable of hybridizing to a target nucleic acid is a loop and two regions existing on both sides form a stem by base pair formation. Examples of the two regions forming the stem include a region capable of hybridizing with a ribosome binding region and a region including the same, a region capable of hybridizing with an initiation codon and a region including the region, and the like.

[0065] このようなヘアピン構造を有することにより、通常は、リボソーム結合領域や開始コド ン等が 2本鎖状態であるため、翻訳に必要な因子が結合することができず、レポータ 一タンパク質への翻訳は実質的に起こらない。さらに、標的核酸とハイブリダィズでき る領域に標的核酸が結合すると、このループが剛直になって伸び、その結果ステム の 2本鎖の全部又は一部が解消して、翻訳開始に必要な因子力 Sリボソーム結合領域 や開始コドン等に結合できるようになり、レポータータンパク質への翻訳が開始する。 [0065] By having such a hairpin structure, the ribosome binding region, the initiation codon, etc. are usually in a double-stranded state, so that factors necessary for translation cannot be bound, and the reporter There is virtually no translation into a single protein. Furthermore, when the target nucleic acid binds to a region that can hybridize with the target nucleic acid, this loop becomes rigid and extends, and as a result, all or part of the double strand of the stem is eliminated, and the factor force S required for translation initiation S It becomes able to bind to the ribosome binding region and initiation codon, and translation into the reporter protein begins.

[0066] リボソーム結合領域と、それを含む領域とハイブリダィズできる領域とが 2本鎖のス テムを形成するような試薬としては、上流より順に、リボソーム結合領域、開始コドン、 及びレポータータンパク質をコードする領域を備え、リボソーム結合領域のさらに上 流に、標的核酸配列とハイブリダィズできる領域を介して、リボソーム結合領域を含む 領域とハイブリダィズできる領域を備える試薬が挙げられる。この試薬は、通常は、リ ポソーム結合領域と、この試薬分子中のリボソーム結合領域を含む領域とハイブリダ ィズできる領域とがハイブリダィズしてステムを形成し、その間に存在する標的核酸相 補的領域をループとするヘアピン構造を採っている。ここに、標的核酸が存在すると 、これが標的核酸相補的領域とハイブリダィズしてループが伸び、リボソーム結合領 域力 S1本鎖状態になる。この高次構造変化により、リボソーム結合領域へのリボソーム の結合が可能になってレポータータンパク質への翻訳が開始される。 [0066] As a reagent in which a ribosome-binding region and a region capable of hybridizing with the ribosome-binding region form a double-stranded system, encode a ribosome-binding region, an initiation codon, and a reporter protein in order from the upstream. A reagent comprising a region, and a region further hybridized with a region containing a ribosome binding region via a region capable of hybridizing with a target nucleic acid sequence is provided further upstream of the ribosome binding region. This reagent usually has a target nucleic acid-complementary region that hybridizes with a region that can hybridize with a region that includes the ribosome-binding region in the reagent molecule and a region that can hybridize with this region. It has a hairpin structure with a loop. If the target nucleic acid is present here, it hybridizes with the target nucleic acid complementary region, and the loop extends, resulting in a ribosome binding region force S1 strand state. This conformational change allows the ribosome to bind to the ribosome binding region and initiates translation into the reporter protein.

[0067] リボソーム結合領域には、原核細胞で機能するもの、真核細胞で機能するもの、ゥ ィルス由来のものなどが含まれる。原核細胞で機能するリボソーム結合領域は、原核 細胞 mRNAにおいてリボソームが結合できるプリンリッチな配列からなる領域をいい 、一般に 3〜9塩基程度からなる。原核細胞で機能するリボソーム結合領域は SD配 歹 IJとも称される。また、真核細胞で機能するリボソーム結合領域としては、例えばコザ ック配列(5'— AGCCACCAUGG— 3') (配列番号 1)、リボソーム内部認識部位(I RES: Internal Ribosome Entry Site)が挙げられる。また、ウィルス由来のリボソーム結 合領域としては、例えばリボソーム内部認識部位(IRES)が挙げられる。ウィルスの I RESはウィルス RNAに含まれる配列であり、宿主のリボソームと結合することによりリ ポソームの立体構造を変化させて、通常はウィルスタンパク質の翻訳を開始させる。 本発明の遺伝子検出用試薬では、ウィルスの IRESを使用してレポータータンパク質 の翻訳を開始させることができる。  [0067] Ribosome binding regions include those that function in prokaryotic cells, those that function in eukaryotic cells, those derived from viruses, and the like. The ribosome-binding region that functions in prokaryotic cells refers to a region consisting of a purine-rich sequence to which ribosomes can bind in prokaryotic cell mRNA, and generally consists of about 3 to 9 bases. The ribosome binding region that functions in prokaryotic cells is also referred to as SD-coordinated IJ. Examples of ribosome binding regions that function in eukaryotic cells include the Kozak sequence (5'—AGCCACCAUGG—3 ′) (SEQ ID NO: 1) and the ribosome internal recognition site (I RES: Internal Ribosome Entry Site). . Examples of the virus-derived ribosome binding region include a ribosome internal recognition site (IRES). The viral I RES is a sequence contained in the viral RNA, which changes the three-dimensional structure of the liposome by binding to the host ribosome and usually initiates translation of the viral protein. With the gene detection reagent of the present invention, translation of a reporter protein can be initiated using viral IRES.

[0068] リボソーム結合領域と開始コドンとの間に存在する塩基数には制限はないが、好ま しくは 3〜: 12塩基程度離れていればよレ、。この範囲であれば、リボソームの結合に始 まる翻訳開始が効率良く行われる。 [0068] The number of bases present between the ribosome binding region and the start codon is not limited, but is preferred. 3 ~: It should be about 12 bases away. Within this range, translation initiation starting with ribosome binding is efficiently performed.

[0069] 開始コドンは、通常 AUGであるが、開始コドンとして機能する限り GUGなどのその 他の配歹 1Jも使用できる。  [0069] The initiation codon is usually AUG, but other combinations 1J such as GUG can be used as long as it functions as an initiation codon.

[0070] レポータータンパク質の種類は特に限定されず、公知のレポータータンパク質を制 限無く使用できる。公知のレポーター遺伝子としては、例えばルシフェラーゼ遺伝子 、分泌型アルカリフォスファターゼ(SEAP)遺伝子、クロラムフエニコールァセチルトラ ンスフェラーゼ(CAT)遺伝子、 j3 _ガラクトシダーゼ遺伝子等が挙げられる。これらの レポーター遺伝子は酵素タンパク質をコードし、酵素反応を利用してその発現を検出 するものであるため、その分検出感度が高くなる。レポーター遺伝子は、緑色蛍光タ ンパク質遺伝子のように、その産物自体の信号を検出するものであってもよレ、。なお 、分泌型アルカリフォスファターゼ、クロラムフエニコールァセチルトランスフェラーゼ、 i3 -ガラクトシダーゼは、その基質生成物が可視光を発するものが多いため、簡単に 酵素活性を検出できる点で好ましい。  [0070] The type of reporter protein is not particularly limited, and any known reporter protein can be used without limitation. Known reporter genes include, for example, a luciferase gene, a secreted alkaline phosphatase (SEAP) gene, a chloramphenicol acetyl transferase (CAT) gene, and a j3_galactosidase gene. Since these reporter genes encode enzyme proteins and detect their expression using an enzyme reaction, the detection sensitivity increases accordingly. The reporter gene may be one that detects the signal of the product itself, such as a green fluorescent protein gene. In addition, secretory alkaline phosphatase, chloramphenicol acetyltransferase, and i3-galactosidase are preferable because their substrate products often emit visible light, so that enzyme activity can be easily detected.

[0071] RBSを含む領域とハイブリダィズできる領域は、この分子中の RBSとハイブリダィズ で るか、又は RBSとそれに隣接する領域とからなる領域をハイブリダィズできる領 域であればよい。ここで、「ハイブリダィズできる」とは、本試薬の使用条件下でハイブ リダィズできることをいい、例えば、原核細胞抽出液中で 37°Cでインキュベートした後 、同溶液中で 37°Cで洗浄した場合に、陽性のハイプリタイズのシグナルが観察され ることが挙げられる。  [0071] The region that can hybridize with the region containing RBS may be a region that can hybridize with the RBS in this molecule or a region composed of RBS and the adjacent region. Here, “can hybridize” means to be able to hybridize under the conditions of use of this reagent. For example, after incubation at 37 ° C. in a prokaryotic cell extract and washing at 37 ° C. in the same solution. In addition, a positive hypritizing signal is observed.

[0072] 特に、この領域と RBSとが相補的であるのが好ましレ、が、標的核酸検出方法を実 施する温度においてハイブリダィズできる限りミスマッチが存在していてもよい。例え ば、この方法の実施温度が 37°Cであり、ノ、イブリダィズ領域が 10塩基以上ある場合 には 10。/ο以上のミスマッチの存在が可能である。  [0072] In particular, it is preferable that this region and RBS are complementary, but mismatches may exist as long as hybridization is possible at the temperature at which the target nucleic acid detection method is performed. For example, if the temperature of this method is 37 ° C and there are 10 or more bases in the iridescence region. There can be a mismatch of more than / ο.

[0073] RBSとハイブリダィズできる領域の長さは、 5〜30塩基程度が好ましぐ 8〜: 10塩基 程度がより好ましい。標的核酸が存在しなくても、この領域と RBSとはハイブリダィズ したり 1本鎖になったりしており、平衡状態にある。この領域の長さが上記範囲であれ ば、このような標的核酸によらない非特異的な 2本鎖の解離が生じにくい。また、前述 したように、標的核酸配列とハイブリダィズできる領域は標的核酸非存在下ではルー プ構造を採っている力 この領域と標的核酸との 2本鎖形成によりループが伸びて、 それによりステムを形成している RBSを含む領域とそれにハイブリダィズできる領域と の 2本鎖状態の全部又は一部が解消する。従って、 RBSを含む領域とハイブリダィズ できる領域の長さが上記範囲であれば、標的核酸配列とハイブリダィズできる領域の 長さが長くなりすぎず、両者間のミスマッチを感度良く検出できるものとなる。 [0073] The length of the region capable of hybridizing with RBS is preferably about 5 to 30 bases, more preferably about 8 to about 10 bases. Even if the target nucleic acid does not exist, this region and RBS are hybridized or single-stranded and are in equilibrium. If the length of this region is in the above range, such nonspecific double-strand dissociation that does not depend on the target nucleic acid hardly occurs. The above Thus, the region that can hybridize with the target nucleic acid sequence has a loop structure in the absence of the target nucleic acid. The loop is extended by the formation of a double strand between this region and the target nucleic acid, thereby forming a stem. All or part of the double-stranded state of the region containing RBS and the region that can hybridize to it is eliminated. Therefore, if the length of the region that can hybridize with the region containing RBS is within the above range, the length of the region that can hybridize with the target nucleic acid sequence does not become too long, and mismatch between them can be detected with high sensitivity.

[0074] 標的核酸配列としては、疾患の遺伝子診断のための検出を行う場合はヒトの疾患 に関与する遺伝子中の配列が挙げられる。また、親子鑑定や法医学鑑定のための 検出を行う場合は遺伝マーカー近傍の配列が挙げられる。また、ヒトに感染した病原 微生物の同定や、食品の微生物汚染を検查するための検出を行う場合は、その微 生物に固有の染色体配列が挙げられる。  [0074] Examples of the target nucleic acid sequence include sequences in genes involved in human diseases when detection for genetic diagnosis of diseases is performed. In the case of detection for parent-child or forensic evaluation, sequences near genetic markers can be mentioned. In addition, when identifying pathogenic microorganisms that have infected humans or detecting foods to detect microbial contamination, chromosome sequences unique to those microorganisms can be mentioned.

[0075] 標的核酸配列とハイブリダィズできる領域は、標的核酸配列の全部又は一部にハ イブリダィズできればょレ、。中でも、標的核酸配列と相補的な領域であることが好まし ぐこれにより 1塩基のミスマッチでも検出できるものとなる。相補的であればよい。そ の長さは、 5〜60塩基程度が好ましぐ 14〜20塩基程度がより好ましい。前述したよ うにこの領域は標的核酸非存在下ではループ構造を採ってレ、るが、標的核酸配列と ハイブリダィズできる領域の長さが上記範囲であれば、標的核酸との 2本鎖形成によ りループを伸ばして RBSの 2本鎖状態を容易に解消でき、かつ標的核酸との間のミ スマッチの検出感度が高くなる。  [0075] The region that can hybridize with the target nucleic acid sequence should be hybridized to all or part of the target nucleic acid sequence. Above all, it is preferable that the region is complementary to the target nucleic acid sequence, so that even a single base mismatch can be detected. It may be complementary. The length is preferably about 5 to 60 bases, more preferably about 14 to 20 bases. As described above, this region takes a loop structure in the absence of the target nucleic acid. However, if the length of the region that can hybridize with the target nucleic acid sequence is within the above range, double-stranded formation with the target nucleic acid occurs. By extending the loop, the double-stranded state of RBS can be easily eliminated, and the detection sensitivity of mismatches with the target nucleic acid is increased.

[0076] いずれにしても、 RBSを含む領域の塩基数に対する、標的核酸とハイブリダィズで きる領域の塩基数の比率は、 1〜: 10程度が好ましぐ 2〜5程度がより好ましい。上記 比率範囲であることにより、標的核酸のループ部分への結合により容易にステムを開 放することができ、かつ標的核酸配列とハイブリダィズできる領域の長さが適当にな つてミスマッチの検出感度が高くなる。  In any case, the ratio of the number of bases in the region capable of hybridizing with the target nucleic acid to the number of bases in the region containing RBS is preferably about 1 to 10 and more preferably about 2 to 5. When the ratio is within the above range, the stem can be easily opened by binding to the loop portion of the target nucleic acid, and the mismatch detection sensitivity is high when the length of the region that can hybridize with the target nucleic acid sequence is appropriate. Become.

[0077] 標的核酸配列とハイブリダィズできる領域は RBSに隣接してレ、てもよく、これらの間 に:!〜 5塩基程度の任意の配列が存在していてもよい。同様に、標的核酸配列とハイ ブリダィズできる領域は RBSを含む領域とハイブリダィズできる領域に隣接していて もよぐこれらの間に 1〜5塩基程度の任意の配列が存在していてもよい。 [0078] また、開始コドンと、それを含む領域とハイブリダィズできる領域とが 2本鎖のステム を形成するような試薬としては、上流より順に、リボソーム結合領域、開始コドン、及び レポータータンパク質をコードする領域を備え、リボソーム結合領域のさらに上流に、 標的核酸配列とハイブリダィズできる領域を介して、開始コドンを含む領域とハイプリ ダイズできる領域を備える試薬が挙げられる。 [0077] The region capable of hybridizing with the target nucleic acid sequence may be adjacent to the RBS, and an arbitrary sequence of about! To 5 bases may exist between them. Similarly, the region that can be hybridized with the target nucleic acid sequence may be adjacent to the region that can hybridize with the region containing RBS, or an arbitrary sequence of about 1 to 5 bases may exist between these regions. [0078] In addition, as a reagent in which a start codon and a region capable of hybridizing with the start codon form a double-stranded stem, the ribosome binding region, the start codon, and the reporter protein are encoded in this order from the upstream. And a reagent comprising a region that can be hybridized with a region containing a start codon via a region that can hybridize with a target nucleic acid sequence further upstream of the ribosome binding region.

[0079] この試薬は、標的核酸の存在により開始コドン力 ^本鎖状態になって、翻訳開始に 必要な因子の結合が可能になり、翻訳が開始される。標的核酸とハイブリダィズでき る領域と、開始コドンとハイブリダィズできる領域とは隣接していてもよぐこれらの間 に:!〜 5塩基程度の任意の配列が存在していてもよい。その他の構成は、リボソーム 結合領域を含むステムを有する試薬と同様である。 [0079] In this reagent, the presence of the target nucleic acid makes the initiation codon strength in a double-stranded state, allowing binding of factors necessary for translation initiation, and translation is initiated. The region that can hybridize with the target nucleic acid and the region that can hybridize with the start codon may be adjacent to each other, or an arbitrary sequence of about! To 5 bases may exist between them. Other configurations are the same as those of the reagent having a stem including a ribosome binding region.

[0080] 本発明の第 1の試薬分子の大きさの上限は、細胞抽出液を用いてレポータータン パク質への翻訳を行うことができるものである限り特に限定されなレ、が、通常 1000〜[0080] The upper limit of the size of the first reagent molecule of the present invention is not particularly limited as long as it can be translated into a reporter protein using a cell extract, but is usually 1000 ~

2000塩基程度とすればょレ、。 If it is about 2000 bases,

[0081] この試薬は、標的核酸とハイブリダィズした場合に、 自己 RNA鎖を切断するリボザ ィムとして機能する領域を含むものであってもよい。 自己切断する位置は、 RNAの切 断によりレポーター遺伝子の翻訳を開始させるような位置であればよいが、代表的に は、標的核酸配列とハイブリダィズできる領域内の位置が挙げられる。この場合、標 的核酸配列とハイブリダィズできる領域は RNAからなり、この領域がリボザィムとして 機能する領域である。このような RNAとして、例えば、標的核酸配列とハイブリダィズ できる領域をァロステリツタエフヱクタ一核酸配列結合部位とする自己切断型ハンマ 一ヘッド型リボザィムゃヘアピン型リボザィムになったものが挙げられる。 [0081] This reagent may contain a region that functions as a ribozyme that cleaves its own RNA strand when hybridized with a target nucleic acid. The self-cleaving position may be a position that initiates translation of the reporter gene by cleaving RNA, but typically includes a position within a region capable of hybridizing with the target nucleic acid sequence. In this case, the region that can hybridize with the target nucleic acid sequence is RNA, and this region functions as a ribozyme. Such RNA includes, for example, a self-cleaving hammer-head type ribozyme having a region capable of hybridizing with a target nucleic acid sequence as a site for binding of a nucleic acid sequence to a hairpin-type ribozyme.

DNAからなる試薬  Reagent consisting of DNA

本発明の第 2の遺伝子検出用試薬は、上記説明した第 1の試薬であって RNAから なるものに転写され得る DNAを含む試薬である。この DNAは通常 2本鎖 DNAであ る。この DNAは、 RBSを含む領域とハイブリダィズできる領域のさらに上流に、転写 に必要なプロモーター領域を備えてレ、ればよレ、。  The second gene detection reagent of the present invention is a reagent containing DNA that can be transcribed into the first reagent described above and composed of RNA. This DNA is usually double-stranded DNA. This DNA should have a promoter region necessary for transcription upstream of the region that can hybridize with the region containing RBS.

[0082] レポーター遺伝子を含むプラスミドが市販されている力 S、これには、通常プロモータ 一領域、リボソーム結合領域、開始コドン、及びレポーター遺伝子が含まれている。 従って、この市販のレポータープラスミドのプロモーター領域とリボソーム結合領域と の間に、 RBS又は開始コドンを含む領域とハイブリダィズできる領域、及び標的核酸 配列とハイブリダィズできる領域に転写され得る DNA配列を挿入すればょレ、。この 配列は化学合成することができる。 [0082] The force S for which a plasmid containing a reporter gene is commercially available, usually includes a promoter region, a ribosome binding region, an initiation codon, and a reporter gene. Therefore, a DNA sequence that can be transcribed into a region that can hybridize with the region containing RBS or the start codon and a region that can hybridize with the target nucleic acid sequence should be inserted between the promoter region and the ribosome binding region of this commercially available reporter plasmid. Les. This sequence can be chemically synthesized.

[0083] 本発明の第 2の試薬は分解され難い DNAを含むため、保存安定性がよい試薬と なる。 [0083] Since the second reagent of the present invention contains DNA that is difficult to be decomposed, it is a reagent with good storage stability.

αι 貴ィ云 キット  αι Kiyun Kit

本発明の遺伝子検出用キットは、上記説明した本発明の遺伝子検出用試薬を備え るキットである。  The gene detection kit of the present invention is a kit provided with the gene detection reagent of the present invention described above.

[0084] また、リボソーム結合領域が原核細胞で機能するものである場合は、原核細胞抽出 液を備えていればよい。通常、被験試料中に転写 '翻訳に必要な因子が含まれるた め、この細胞抽出液によりレポータータンパク質への翻訳、又は転写及び翻訳が行 われる。なお、リボソーム結合領域が真核細胞で機能するものやウィルス由来のもの である場合は、真核細胞抽出液を利用すればょレ、。  [0084] When the ribosome-binding region functions in prokaryotic cells, a prokaryotic cell extract may be provided. Usually, since a factor necessary for transcription and translation is contained in a test sample, translation into a reporter protein, or transcription and translation is performed by this cell extract. If the ribosome binding region functions in eukaryotic cells or is derived from a virus, use a eukaryotic cell extract.

[0085] 細胞抽出液は、 Zubay法(Zubay, G. Ann. Rev. Genet. 1978, 7, 267)により作製す ること力 Sできる力 市販品を使用してもよい。  [0085] The cell extract may be prepared by the Zubay method (Zubay, G. Ann. Rev. Genet. 1978, 7, 267).

[0086] また本発明のキットは、さらに、 DNAとハイブリダィズした RNAを特異的に切断す る活性を有する RNA分解酵素を備えていてよレヽ。この RNA分解酵素は、 DNAと R NAとが完全に相補的である領域でその RNAを切断するものであることが好ましレ、。 これにより、試薬 RNAの標的核酸配列とハイブリダィズできる領域が標的核酸である DNAの対応領域と完全に相補的である場合に 2本鎖中の RNAを切断する。 RNas eHは非常に高いミスマッチ認識能を有しており、 1塩基多型の検出を確実に行える ようになる。この RNA分解酵素はエンドヌクレアーゼであることが好ましぐこれにより 、標的核酸とハイブリダィズした試薬 RNAを効率良く切断して、標的核酸を試薬 RN Aから乖離させることができる。このような RNA分解酵素として、 RNaseHが挙げられ る。 本発明の遺伝子検出方法は、被験試料と本発明の遺伝子検出用試薬とを混合す る第 1工程と、遺伝子検出用試薬からのレポータータンパク質の発現量を、被験試料 の非存在下での本発明の遺伝子検出用試薬からのレポータータンパク質の発現量 と比較することにより、被験試料中の標的核酸の有無を判定する第 2工程とを含む方 法である。 [0086] The kit of the present invention may further comprise an RNase having an activity of specifically cleaving RNA hybridized with DNA. This RNase is preferably one that cleaves RNA in a region where DNA and RNA are completely complementary. As a result, when the region that can hybridize with the target nucleic acid sequence of the reagent RNA is completely complementary to the corresponding region of the DNA that is the target nucleic acid, the RNA in the double strand is cleaved. RNaseH has a very high mismatch recognition ability, so it can reliably detect single nucleotide polymorphisms. This RNase is preferably an endonuclease, whereby the reagent RNA hybridized with the target nucleic acid can be efficiently cleaved and the target nucleic acid can be separated from the reagent RNA. An example of such an RNase is RNaseH. In the gene detection method of the present invention, a test sample and the gene detection reagent of the present invention are mixed. In the test sample by comparing the expression level of the reporter protein from the gene detection reagent with the expression level of the reporter protein from the gene detection reagent of the present invention in the absence of the test sample. And a second step of determining the presence or absence of the target nucleic acid.

[0087] 遺伝子検出用試薬のリボソーム結合領域が原核細胞で機能するものである場合は 、原核細胞抽出液の存在下でレポータータンパク質の発現を行えばよい。  [0087] When the ribosome binding region of the gene detection reagent functions in prokaryotic cells, the reporter protein may be expressed in the presence of a prokaryotic cell extract.

[0088] 被験試料としては、それには限定されないが、例えば、口腔内の粘膜細胞のような 採取された細胞、血液、唾液、毛髪などが挙げられる。また、細菌感染が疑われる食 品なども使用できる。  [0088] Examples of test samples include, but are not limited to, collected cells such as mucosal cells in the oral cavity, blood, saliva, hair, and the like. Foods that are suspected of bacterial infection can also be used.

[0089] 第 1工程において、被験試料は、試料中に核酸が露出している場合はそのまま使 用すればよいが、通常は、常法に従い細胞を破砕又は溶解して力 使用すればよい 。また、細胞破砕液又は細胞溶解液に対して標的核酸配列を PCRで増幅してから 用いれば一層感度が向上する。  [0089] In the first step, the test sample may be used as it is when the nucleic acid is exposed in the sample, but it is usually sufficient to use the cells by crushing or lysing the cells according to a conventional method. In addition, the sensitivity is further improved if the target nucleic acid sequence is amplified by PCR with respect to the cell lysate or cell lysate.

[0090] 本発明試薬の使用量は、試薬が RNAを含むものである場合は被験試料に対して 、モル比で 1〜10倍程度とすればよぐ試薬が DNAの場合はモル比で 0· 01〜0. 1 倍程度とすればよい。また、細胞抽出液の使用量は、 1被験試料に対して 2. 5〜10 /i L程度とすればよい。  [0090] The amount of the reagent of the present invention to be used should be about 1 to 10 times in molar ratio with respect to the test sample when the reagent contains RNA. It should be about 0.1 times. In addition, the amount of cell extract used may be about 2.5 to 10 / iL per test sample.

[0091] これらを混合した後、通常 25〜42°C程度で、 10〜60分間程度インキュベートすれ ばよい。  [0091] After mixing these, it is usually incubated at about 25-42 ° C for about 10-60 minutes.

[0092] 第 1工程において、被験試料と本発明の遺伝子検出用試薬とを混合する際に、さら に DNAとハイブリダィズした RNAを特異的に分解する RNA分解酵素を混合するこ とができる。この RNA分解酵素はハイブリダィズ前の 1本鎖 RNAを分解しないため、 これらの混合順序は特に限定されず、例えば、 RNA分解酵素と遺伝子検出用試薬 とを混合したものを被験試料に添加してもよい。  [0092] In the first step, when the test sample and the gene detection reagent of the present invention are mixed, an RNA-degrading enzyme that specifically degrades RNA hybridized with DNA can be mixed. Since this RNase does not degrade single-stranded RNA before hybridization, the mixing order thereof is not particularly limited. For example, a mixture of RNase and a gene detection reagent may be added to a test sample. Good.

[0093] このような RNA分解酵素を使用すれば 1塩基のミスマッチでも検出できるため、本 発明方法は 1塩基多型の検出方法となる。この場合、遺伝子検出用試薬中の標的核 酸配列とハイブリダィズできる領域は、標的核酸配列の野生型配列又は予想される 1 塩基変異型配列のレ、ずれ力、と相補的な配列を有してレ、ればよレ、。 [0094] 第 2工程では、レポータータンパク質の発現をその種類に応じた方法で検出すれ ばよレ、。これらのタンパク質の発現は以下のような市販のキットを用いて検出及び測 定すること力 Sできる。 [0093] By using such an RNase, even a single-base mismatch can be detected, so the method of the present invention is a single-nucleotide polymorphism detection method. In this case, the region that can hybridize with the target nucleic acid sequence in the reagent for gene detection has a sequence complementary to the wild type sequence of the target nucleic acid sequence or the predicted single nucleotide variant sequence, the displacement force, and the like. Let's do it. [0094] In the second step, reporter protein expression may be detected by a method according to the type. The expression of these proteins can be detected and measured using the following commercially available kits.

例えばノレシフェラーゼの発現は、細胞溶解液に発光基質であるルシフェリン (例えば 東洋インキ社製)を添加し基質の分解による発光をルミノメーター、液体シンチレーシ ヨンカウンター又はトップカウンタ一等を用いて検出'測定すればよい。アルカリフォス ファターゼの発現は、例えば L x Mi_Phos530 (和光純薬社製)を用いて検出'測定で きる。クロラムフエニコールァセチルトランスフェラーゼの発現は、 FAST CAT Chrolam phenicol Acetyltransferase Assay Kit (和光純薬社製)を用いて検出'測定できる。 β - ガラクトシダーゼの発現は Aurora Gal-XE (和光純薬社製)を用いて検出'測定できる  For example, the expression of noluciferase is detected using a luminometer, a liquid scintillation counter, a top counter, or the like by adding luciferin (for example, manufactured by Toyo Ink) as a luminescent substrate to the cell lysate and luminescence due to decomposition of the substrate. Just measure. The expression of alkaline phosphatase can be detected and measured using, for example, L x Mi_Phos530 (manufactured by Wako Pure Chemical Industries, Ltd.). The expression of chloramphenicol acetyltransferase can be detected and measured using FAST CAT Chrolam phenicol Acetyltransferase Assay Kit (manufactured by Wako Pure Chemical Industries, Ltd.). β-galactosidase expression can be detected and measured using Aurora Gal-XE (Wako Pure Chemical Industries, Ltd.)

[0095] 第 2工程では、被験試料が存在しない場合、すなわち本発明の試薬を同じ条件で インキュベートした場合と、被験試料が存在する場合との間で、レポータータンパク質 の発現量を比較すればよい。タンパク質の発現量は、 目視などにより直接比較するこ ともできる力 各場合のタンパク質発現量を測定した上で比較してもよレ、。 [0095] In the second step, the expression level of the reporter protein may be compared between when the test sample is not present, that is, when the reagent of the present invention is incubated under the same conditions and when the test sample is present. . The amount of protein expression can be compared directly by visual observation. The protein expression level in each case can be measured and compared.

[0096] 各場合のタンパク質発現量を測定する場合の判定基準は、それには限定されない 、例えば、被験試料の存在によりタンパク質発現量が 3倍以上に向上すれば、被 験試料中に標的核酸配列が存在していると判定することができる。  [0096] The criteria for measuring the protein expression level in each case are not limited thereto. For example, if the protein expression level is improved 3 times or more due to the presence of the test sample, the target nucleic acid sequence in the test sample is determined. Can be determined to exist.

(IV)遺伝子檢出用試薬 しての使用  (IV) Use as a gene extraction reagent

本発明の第 1の使用は、標的核酸配列とハイブリダィズできる領域、リボソーム結合 領域、開始コドン、及びレポータータンパク質をコードする領域を備える核酸であって 、前記標的核酸とのハイブリダィズにより高次構造変化が誘起され、レポータータン パク質への翻訳が開始される核酸の遺伝子検出用試薬としての使用である。  A first use of the present invention is a nucleic acid comprising a region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, wherein the higher-order structural change is caused by hybridization with the target nucleic acid. Use as a gene detection reagent of a nucleic acid that is induced to initiate translation into a reporter protein.

[0097] 本発明の第 2の使用は、標的核酸配列とハイブリダィズできる領域、リボソーム結合 領域、開始コドン、及びレポータータンパク質をコードする領域を備える RNAであり、 標的核酸とのハイブリダィズにより誘起される高次構造変化がレポータータンパク質 への翻訳を開始させる RNAに転写され得る DNAの遺伝子検出用試薬としての使用 である。 列 [0097] A second use of the present invention is RNA comprising a region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, and is highly induced by hybridization with the target nucleic acid. The next structural change is the use of DNA as a gene detection reagent that can be transcribed into RNA that initiates translation into a reporter protein. Column

以下、本発明を実施例、及び試験例を示してより詳細に説明するが、本発明はこれ らに限定されるものではない。  Hereinafter, the present invention will be described in more detail with reference to Examples and Test Examples, but the present invention is not limited to these.

^M l (MB制御されたルシフヱラーゼ発現铸型の構築)  ^ M l (construction of MB-controlled luciferase expression pattern)

ホタルルシフェラーゼ遺伝子を含むプラスミド pGL3はプロメガから購入した。ター ゲットと相補的な 3'末端側部分領域及び SD配列を含むフォワードプライマー(5' _d( GGT CTG AAG GTT TAT TAG AAG GAG ATA TAC CAA TGG AAG ACG CCA AAA ACA TA)-3,:配列番号 2) 5pmol及びリバースプライマー(5'_d(TAT TCA TT A CAC GGC GAT CTT TCC G)- 3':配列番号 3) 5pmolを含む 25 μ 1の反応混合 物を用いて、プラスミド pGL3を铸型として第 1回目の PCRを行った。第 1回目の PCR では、 5ngの pGL3ベクター、 1. 25Uの Pfu Ultra HF DNAポリメラーゼ(ストラ タジーン社)、 5nmolの各 dNTPs (東洋紡績社)、及び 2. 5 μ Lの 10 X Pfu Ultra HF反応バッファーを用いた。 PCR条件は、 95°Cで 3分間、(95°Cで 45秒間、 54°C で 45秒間、 72°Cで 1分間)のセットを 30サイクル、 72°Cで 10分間の条件とした。  Plasmid pGL3 containing the firefly luciferase gene was purchased from Promega. Forward primer containing 3 'terminal partial region complementary to the target and SD sequence (5' _d (GGT CTG AAG GTT TAT TAG AAG GAG ATA TAC CAA TGG AAG ACG CCA AAA ACA TA) -3 ,: SEQ ID NO: 2 ) 5 pmol and reverse primer (5'_d (TATTCTATTACAC GGC GATCTTTCC G) -3 ': SEQ ID NO: 3) Using a 25 μ1 reaction mixture containing 5 pmol, the plasmid pGL3 was used as a saddle. The first PCR was performed. The first round of PCR included 5 ng of pGL3 vector, 1.25 U of Pfu Ultra HF DNA polymerase (Stratagene), 5 nmol of each dNTPs (Toyobo), and 2.5 μL of 10 X Pfu Ultra HF reaction. A buffer was used. PCR conditions were 95 ° C for 3 minutes (95 ° C for 45 seconds, 54 ° C for 45 seconds, 72 ° C for 1 minute) for 30 cycles and 72 ° C for 10 minutes.

[0098] ターゲットと相補的な 5'末端側部分領域及び T7プロモーターを含むユニバーサル プライマー 5,-d(GAA ATT AAT ACG ACT CAC TAT AGG GAG ACC ACA ACG GTT TCC CTC TAT CTC CTG GTC TGA AGG TTT A)_3' (配列番号 4)5pmolを 含む 20 μ 1の反応混合物を用いて、 1回目の PCR反応で生成した 2本鎖 DNAを铸型 として第 2回目の PCRを行った。第 2回目の PCRでは、 5pmolのリバースプライマー( 5,- d(TAT TCA TTA CAC GGC GAT CTT TCC G)- 3,:配列番号 5)、 1 /i Lの 1/ 100倍希釈した第 1回目の PCRと同じ PCR反応溶液、 1. 25Uの Pfu Ultra HF DNAポリメラーゼ(ストラタジーン社)、 5nmolの各 dNTPs (東洋紡績社)、及び 2. 5 〃Lの lO X Pfu Ultra HF反応バッファーを用いた。 PCR条件は、 95°Cで 3分間、 (95°Cで 45秒間、 54°Cで 45秒間、 72°Cで 1分間)を 30サイクル、 72°Cで 10分間の 条件とした。 [0098] Universal primer 5 containing a 5 'terminal partial region complementary to the target and T7 promoter, -d (GAA ATT AAT ACG ACT CAC TAT AGG GAG ACC ACA ACG GTT TCC CTC TAT CTC CTG GTC TGA AGG TTT A) A second PCR was performed using 20 μl of the reaction mixture containing 5 pmol of _3 ′ (SEQ ID NO: 4) as a double-stranded DNA generated in the first PCR reaction. In the second PCR, 5 pmol reverse primer (5, -d (TAT TCA TTA CAC GGC GAT CTT TCC G) -3, SEQ ID NO: 5), 1 / i L diluted 1/100 times the first round The same PCR reaction solution as PCR of 1.25 U of Pfu Ultra HF DNA polymerase (Stratagene), 5 nmol of each dNTPs (Toyobo), and 2.5 μL of lO X Pfu Ultra HF reaction buffer . PCR conditions were 95 ° C for 3 minutes (95 ° C for 45 seconds, 54 ° C for 45 seconds, 72 ° C for 1 minute) for 30 cycles and 72 ° C for 10 minutes.

[0099] これにより、 MB—制御されたルシフェラーゼ mRNA転写用の 2本鎖 DNAが得ら れた。この DNAの塩基配列を配列番号 6に示す。配列番号 6において、塩基番号 1 〜22が T7—プロモーター領域であり、塩基番号 73〜77の 6塩基が SD配列(リボソ ーム結合配列)であり、塩基番号 86〜: 1722が開始コドンから始まるルシフェラーゼ 遺伝子である。また、塩基番号 54〜69は、 mRNAに転写された場合にターゲット配 列である CCR5と相補的な配列を与える配列である。 [0099] This resulted in double-stranded DNA for MB-controlled luciferase mRNA transcription. The base sequence of this DNA is shown in SEQ ID NO: 6. In SEQ ID NO: 6, base numbers 1 to 22 are T7-promoter regions, and 6 bases of base numbers 73 to 77 are SD sequences (ribosomes). A luciferase gene whose base numbers 86 to 1722 start from the start codon. Base numbers 54 to 69 are sequences that give a complementary sequence to CCR5, which is the target sequence, when transcribed into mRNA.

[0100] この 2本鎖 DNAより、 T7 MEGAshortscriptキット(アンビオン社)を用いて、 MB 制御されたルシフェラーゼ mRNA力 ST7ランオフ転写により得られた。簡単に説明す れば、錡型 DNAの第 2回目の PCR溶液を 3 μ Lを含む Τ7転写反応混合物(10 μ L )を 37°Cで 120分間インキュベートした。この反応混合物に 1Uの DNase Iを添加し 、混合物をさらに 15分間インキュベートした。  [0100] From this double-stranded DNA, MB-controlled luciferase mRNA force was obtained by ST7 run-off transcription using the T7 MEGAshortscript kit (Ambion). Briefly, Τ7 transcription reaction mixture (10 μL) containing 3 μL of the second PCR solution of vertical DNA was incubated at 37 ° C for 120 minutes. 1 U DNase I was added to the reaction mixture and the mixture was incubated for an additional 15 minutes.

[0101] 次いで、 RNeasy MinElute Cleanupキット(キアゲン社)を用いて mRNAを精 製した。 mRNAの濃度を 260nmの吸収を測定することにより決定した。  [0101] Next, mRNA was purified using the RNeasy MinElute Cleanup kit (Qiagen). The concentration of mRNA was determined by measuring the absorbance at 260 nm.

[0102] このようにして得られた MB—ルシフェラーゼ mRNAの構造を図 1に示す。この RN Aは、レポーター遺伝子対応部分と、その上流に制御ヘアピン構造を有する。ヘアピ ン構造は、 8塩基長さのステムと 19塩基長さのループを有する。ステムには 6塩基長 さの RBSが含まれる。ループを含む 18塩基がヒト CCケモキンレセプター 5 (CCR5) 遺伝子の第 620〜635番目の塩基配列(5, -AATAAACCTTCAGACC-3 ':配 列番号 7)に相補的な配列である。  [0102] The structure of the thus obtained MB-luciferase mRNA is shown in FIG. This RNA has a reporter gene corresponding portion and a regulatory hairpin structure upstream thereof. The hairpin structure has an 8 base long stem and a 19 base long loop. The stem contains 6 bases of RBS. The 18 bases including the loop are complementary to the 620th to 635th base sequences of the human CC chemokine receptor 5 (CCR5) gene (5, -AATAAACCTTCAGACC-3 ': SEQ ID NO: 7).

CCR5は、 HIV—1コアレセプターであり、その配列の多様性は HIV—1感染の促進 /遅延のハプロタイプマーカーと考えられる。従って、この配列の選択性は重要であ る。  CCR5 is an HIV-1 core receptor, and its sequence diversity is considered a haplotype marker for promoting / delaying HIV-1 infection. Therefore, the selectivity of this sequence is important.

^ iルシフェラーゼの翻訳と化学発光解析)  ^ i Luciferase translation and chemiluminescence analysis)

ターゲットの CCR5オリゴデォキシヌクレオチド(18pmol)の存在下又は非存在下 で、 1. 8pmolの実施例 1で得た铸型 MB—ルシフェラーゼ mRNAを含む再構築さ れた E. coli翻訳溶液 (T7—トランスクリプション/トランスレーションカップルド、ピュ アシステムクラシック 1、ポストゲノム研究所社)の中で In Vitro翻訳を行った。合計 容量 10 μ Lの反応混合物を 37°Cで 60分間インキュベートした。  Reconstructed E. coli translation solution (T7) containing 1.8 pmol of the truncated MB-luciferase mRNA obtained in Example 1 in the presence or absence of the target CCR5 oligodeoxynucleotide (18 pmol) —Transcription / translation coupled, Pure System Classic 1, Post Genome Laboratories). A total volume of 10 μL of the reaction mixture was incubated at 37 ° C. for 60 minutes.

[0103] ターゲット核酸としては、 CCR5遺伝子の第 620〜635番目の塩基配列を含むオリ ゴヌクレオチド(5 ' -CCGTAAATAAACCTTCAGACCAGAGA-3 ':配列番号 8 )をフルマッチオリゴデォキシヌクレオチドとして用いた。また、配列番号 8において、 塩基番号 13の Cを Tに 1塩基変異させたもの、及び塩基番号 13の Cを Aに 1塩基変 異させたものを、それぞれ 1塩基ミスマッチオリゴデォキシヌクレオチドとして用いた。 さらに、塩基番号 13の Cを Tに変異させるとともに塩基番号 14の Tを Aに変異させた ものを、 2塩基ミスマッチオリゴデォキシヌクレオチドとして用いた。 [0103] As the target nucleic acid, an oligonucleotide (5'-CCGTAAATAAACCTTCAGACCAGAGA-3 ': SEQ ID NO: 8) containing the 620th to 635th base sequences of the CCR5 gene was used as a full-matched oligonucleotide. In SEQ ID NO: 8, Those obtained by mutating C of base number 13 to T by 1 base and those obtained by mutating C of base number 13 by 1 base to A were used as 1-base mismatched oligonucleotides, respectively. Further, a C-mutated C at base number 13 and a T-mutated base T at base number 14 were used as a 2-base mismatched oligonucleotide.

[0104] 各サンプルを翻訳後、 2. 5 μ Lを 100 μ Lのルシフェラーゼアツセィ試薬(プロメガ 社)と混合した。 102. を 96穴プレートに移して Wallacl420システムを用いて 化学発光強度を測定した。  [0104] After translation of each sample, 2.5 μL was mixed with 100 μL of luciferase Atsey reagent (Promega). 102. was transferred to a 96-well plate and the chemiluminescence intensity was measured using the Wallacl420 system.

[0105] 結果を図 2に示す。図 2は、フルマッチオリゴデォキシヌクレオチド、及びミスマッチ オリゴデォキシヌクレオチドの存在下での化学発光強度を、これらのターゲットが存在 しない場合の化学発光強度に対する相対値で表したグラフである。  [0105] The results are shown in FIG. FIG. 2 is a graph showing the chemiluminescence intensity in the presence of a fully-matched oligodeoxynucleotide and a mismatched oligodeoxynucleotide as a relative value to the chemiluminescence intensity in the absence of these targets.

ターゲット非存在下に比べて、フルマッチオリゴデォキシヌクレオチド存在下では、約 Compared to the absence of target, the presence of full-matched oligonucleotides is about

3倍の発光強度が観察された。また、 Cから Tへ変異した 1塩基ミスマッチオリゴデォ キシヌクレオチド存在下では、ターゲット非存在下の約 2倍の発光強度が観察されたThree times the emission intensity was observed. In addition, in the presence of a single-base mismatched oligonucleotide that was mutated from C to T, a luminescence intensity approximately twice that in the absence of the target was observed.

。また、 2塩基ミスマッチオリゴデォキシヌクレオチド存在下、及び Cから Aへ変異した. Also mutated from C to A in the presence of 2-base mismatched oligodeoxynucleotides

1塩基ミスマッチオリゴデォキシヌクレオチドの存在下では、ターゲット非存在下での 発光強度と差が認められなかった。 In the presence of a single-base mismatched oligonucleotide, no difference was observed from the emission intensity in the absence of the target.

実施例 3 (ノレシフェラーゼの転写/翻訳と化学発光解析)  Example 3 (Transcription / translation of chemoluminescence and chemiluminescence analysis)

1. 8pmolの铸型 MB—ルシフェラーゼ mRNAに代えて、 0. 2pmolの MB—ルシ フェラーゼ発現 dsDNA铸型を用いた他は、実施例 2と同様の操作を行った。  1. The same procedure as in Example 2 was performed, except that 0.2 pmol of MB-luciferase-expressing dsDNA cage was used in place of 8 pmol of MB-luciferase mRNA.

[0106] 铸型 MB—ルシフェラーゼ mRNAの 1 · 8pmolに代えて MB—ルシフェラーゼ発現 dsDNAの 0. 2pmolを用いた他は、実施例 2と同様にして、 CCR5遺伝子の部分配 歹 IJDNAと、フルマッチオリゴデォキシヌクレオチド、及び 3種のミスマッチオリゴデォキ シヌクレオチドと作用させた。  [0106] Partial distribution of CCR5 gene in the same manner as in Example 2 except that 0.2 pmol of MB-luciferase expression dsDNA was used instead of 1 · 8 pmol of vertical MB-luciferase mRNA 歹 IJDNA and full-match oligo It was reacted with deoxynucleotides and three mismatched oligodeoxynucleotides.

[0107] 結果を図 3に示す。ターゲット非存在下に比べて、フルマツチオリゴデォキシヌタレ ォチド存在下では、約 8倍の発光強度が観察された。また、 Cから Tへ変異した 1塩基 ミスマッチオリゴデォキシヌクレオチド存在下でも、ターゲット非存在下の約 5倍の発 光強度が観察された。また、 2塩基ミスマッチオリゴデォキシヌクレオチド存在下、及 び Cから Aへ変異した 1塩基ミスマッチオリゴデォキシヌクレオチドの存在下では、タ 一ゲット非存在下に比べて、約 2倍の発光強度が観察された。 The results are shown in FIG. About 8 times higher luminescence intensity was observed in the presence of flumati oligodeoxy tantalate than in the absence of target. In addition, even in the presence of a 1-base mismatched oligodeoxynucleotide mutated from C to T, an emission intensity about 5 times that in the absence of the target was observed. In addition, in the presence of a 2-base mismatch oligonucleotide and in the presence of a 1-base mismatch oligonucleotide mutated from C to A, About twice the emission intensity was observed compared to the absence of one get.

[0108] 遺伝子検出用試薬として、 RNAを用いるより 2本鎖 DNAを用いる方力 一層高感 度で遺伝子変異を検出でき、 1塩基の違いも確実に検出できることが分かる。 [0108] It can be seen that gene mutations can be detected with higher sensitivity, and differences in single bases can be detected more reliably than when RNA is used as a gene detection reagent.

[0109] また、図 4に、各反応混合物の 102. 5 μ Lを 250 μ Lエツペンドルフチューブに移し て、その化学発光像を Versadoc3000で測定したものを示す。図 4力、ら、遺伝子の 1 塩基の変異でも目視により明確に把握できることが分かる。 [0109] Fig. 4 shows 102.5 μL of each reaction mixture transferred to a 250 μL Eppendorf tube and its chemiluminescence image measured by Versadoc3000. Figure 4 shows that even a single base mutation in a gene can be clearly identified by visual inspection.

翻訳段階でのターゲット核酸配列との相互作用の確認)  Confirmation of interaction with target nucleic acid sequence at translation stage)

CCR5フルマッチオリゴデォキシヌクレオチド (18pmol)の存在下又は非存在下で、 0. 2pmolの錡型 MB—ルシフェラーゼ DNAを含む再構築されたリボソーム及び tR NAを含まないセルフリー T7_転写/翻訳、ピュアシステムクラシック 1 (ポストゲノム 研究所社)の中で In Vitro転写を行った。詳しくは、合計容量 10 μ Lの反応混合物 を 37°Cで 60分間インキュベートした。 18pmolの CCR5フルマツチオリゴデォキシヌ クレオチドを用いた。転写反応の効率は、 CCR5フルマツチオリゴデォキシヌクレオチ ド存在下における転写 mRNAの希釈溶液(0, 20, 40, 60, 80, 100%)を内部標準 とし、 CCR5フルマッチオリゴデォキシヌクレオチド非存在下における転写量と比較す ることによって行った。  Cell-free T7_transcription / translation without reconstituted ribosomes containing 0.2 pmol of truncated MB-luciferase DNA and tRNA in the presence or absence of CCR5 full-matched oligonucleotide (18 pmol) In Vitro transcription was performed in Pure System Classic 1 (Post Genome Laboratories). Specifically, a total volume of 10 μL of the reaction mixture was incubated at 37 ° C for 60 minutes. 18 pmol of CCR5 full-match oligodeoxynucleotide was used. The efficiency of the transcription reaction was determined by using a diluted mRNA solution (0, 20, 40, 60, 80, 100%) of transcription mRNA in the presence of CCR5 full-matched oligonucleotide as an internal standard. This was done by comparing the amount of transcription in the presence.

[0110] 図 5に、各反応混合物の化学発光像を ATTOデンシトグラフで測定したものを示す 。フルマッチオリゴデォキシヌクレオチドの存在下では、このターゲットヌクレオチドが 存在しない場合と同程度の発光強度が観察された。  [0110] Fig. 5 shows the chemiluminescence images of each reaction mixture measured by ATTO densitograph. In the presence of the full-matched oligonucleotide, the same emission intensity as that in the absence of the target nucleotide was observed.

[0111] このこと力 、転写段階だけでは、ターゲットによる翻訳阻害は実質的に検出できな レ、ことが分かる。  [0111] From this fact, it can be seen that the translational inhibition by the target cannot be detected substantially only by the transcription stage.

15 (ターゲット の 俘 J  15 (Target 俘 J

実施例 2において、ターゲットとして CCR5フルマッチオリゴデォキシヌクレオチドの 使用量を、 0〜22pmoほで変化させて、化学発光強度を測定した(図 6)。 CCR5フ ルマッチオリゴデォキシヌクレオチドの 7pmol程度で、化学発光強度はやや飽和す るが、それ以下の濃度では、ターゲット量と発光強度はほぼ比例していることが分か る。このこと力 、直線性の点で、本ルシフェラーゼ発現铸型は標的核酸配列の検出 、定量に好適に使用できることが分かる。 実施例 6 (DNA分解酵素の併用) In Example 2, chemiluminescence intensity was measured by changing the amount of CCR5 full-matched oligonucleotides used as targets at 0-22 pmo (FIG. 6). At about 7 pmol of CCR5 full-matched oligonucleotide, the chemiluminescence intensity is slightly saturated, but at lower concentrations, the target amount and luminescence intensity are almost proportional. In view of this force and linearity, it can be seen that the present luciferase expression type can be suitably used for detection and quantification of the target nucleic acid sequence. Example 6 (Combined use of DNA degrading enzymes)

< MB制御されたルシフェラーゼ発現鎳型の構築 >  <Construction of MB-controlled luciferase expression type>

PCRプライマーとして以下のものを用い、プラスミド pBESTluc (プロメガ社)を铸型と した他は実施例 1と同様にして、 MB -制御されたルシフェラーゼ mRNA転写用の 2 本鎖 DNAを得た。この 2本鎖 DNAから転写されるルシフェラーゼ mRNAは、標的 核酸配列とハイブリダィズできる領域として、 CCR5の第 620〜637番目の塩基配列 (5' -AATAAACCTTCAGACCAG-3':配列番号 9)に相補的な配列を有する。 その他は、実施例 1で得た 2本鎖 DNA力、ら得られるルシフヱラーゼ mRNAと同様で ある。  The following were used as PCR primers, and double-stranded DNA for MB-controlled luciferase mRNA transcription was obtained in the same manner as in Example 1 except that the plasmid pBESTluc (Promega) was in the form of a cage. The luciferase mRNA transcribed from this double-stranded DNA is complementary to the 620th to 637th base sequences of CCR5 (5'-AATAAACCTTCAGACCAG-3 ': SEQ ID NO: 9) as a region capable of hybridizing with the target nucleic acid sequence. Have Others are the same as the double-stranded DNA strength obtained in Example 1 and the luciferase mRNA obtained.

第 1回目 PCR  1st PCR

フォワードプライマー(5,_d(GGT CTG AAG GTT TAT TAG AAG GAG ATA TAC Forward primer (5, _d (GGT CTG AAG GTT TAT TAG AAG GAG ATA TAC

CAA TGG AAG ACG CCA AAA ACA TA)_3':配列番号 2) CAA TGG AAG ACG CCA AAA ACA TA) _3 ': SEQ ID NO: 2)

リバースプライマー(5'— d(TAT TCA TTA CAA TTT GGA CTT TCC GCC)— 3,:酉己 列番号 10)  Reverse primer (5'—d (TAT TCA TTA CAA TTT GGA CTT TCC GCC) —3: 酉 己 column number 10)

第 2回目 PCR  2nd PCR

ユニバーサルプライマー(5,-d(GAA ATT AAT ACG ACT CAC TAT AGG GAG A CC ACA ACG GTT TCC CTC TAT CTC CTG GTC TGA AGG TTT A)-3':酉己歹 lj 番号 4)  Universal primer (5, -d (GAA ATT AAT ACG ACT CAC TAT AGG GAG A CC ACA ACG GTT TCC CTC TAT CTC CTG GTC TGA AGG TTT A) -3 ': 酉 己 歹 lj number 4)

リバースプライマー( 5,— d(TAT TCA TTA CAA TTT GGA CTT TCC GCC)— 3,:酉己 列番号 10)  Reverse primer (5, — d (TAT TCA TTA CAA TTT GGA CTT TCC GCC) — 3, 酉 己 column number 10)

このようにして得られた 1 · 8pmolの MB—ルシフェラーゼ mRNAを、ターゲットの C CR5オリゴデォキシヌクレオチド (1. 8pmol)の存在下又は非存在下で、再構築され た E. coli翻訳溶液 (T7—トランスクリプション/トランスレーションカップルド、ピュア システムクラシック 1、ポストゲノム研究所社)の中で In Vitro翻訳を行った。合計容 量 10 μ Lの反応混合物を 37°Cで 60分間インキュベートした。  The 1 · 8 pmol MB-luciferase mRNA thus obtained was reconstituted in the presence or absence of the target CCR5 oligodeoxynucleotide (1.8 pmol) in E. coli translation solution ( T7—Transcription / Translation Coupled, Pure System Classic 1, Post Genome Laboratories). The reaction mixture with a total volume of 10 μL was incubated at 37 ° C. for 60 minutes.

[0112] また、 Tth RNaseH (0. 1U ;東洋紡績社)を含む反応混合物を用いて上記と同 様の操作を行った。 [0112] Further, the same operation as described above was performed using a reaction mixture containing Tth RNaseH (0.1 U; Toyobo Co., Ltd.).

[0113] ターゲット核酸としては、 CCR5遺伝子の第 620〜635番目の塩基配列を有するォ リゴヌクレオチド(5, -AATAAACCTTCAGACC-3 ':配列番号 1 1 )をフルマツチ オリゴデォキシヌクレオチドとして用いた。また、配列番号 1 1において、塩基番号 8の Cを Tに 1塩基変異させたものを 1塩基ミスマッチオリゴデォキシヌクレオチドとして用 いた。 [0113] The target nucleic acid is a DNA having the 620th to 635th base sequences of the CCR5 gene. Ligonucleotide (5, -AATAAACCTTCAGACC-3 ′: SEQ ID NO: 1 1) was used as a full-match oligodeoxynucleotide. Further, in SEQ ID NO: 11, the one obtained by mutating C of base number 8 to T by 1 base was used as a 1 base mismatch oligodeoxynucleotide.

各サンプルを翻訳後、 2. 5 μ Lを 100 μ Lのルシフェラーゼアツセィ試薬(プロメガ社 )と混合した。 102. を 96穴プレートに移して Wallac l400システムを用いて化 学発光強度を測定した。  After translation of each sample, 2.5 μL was mixed with 100 μL of Luciferase Atsey Reagent (Promega). 102. was transferred to a 96-well plate and the chemiluminescence intensity was measured using the Wallac l400 system.

[0114] 結果を図 7に示す。図 7は、フルマッチオリゴデォキシヌクレオチド、及び 1塩基ミス マッチオリゴデォキシヌクレオチドの存在下での化学発光強度を、ターゲット及び RN aseHが存在しなレ、場合の化学発光強度に対する相対値で表したグラフである。また 、レーン:!〜 3は RNaseH非存在下での結果であり、レーン 4〜6は RNaseH存在下 での結果である。 [0114] The results are shown in FIG. Figure 7 shows the chemiluminescence intensity in the presence of full-matched oligonucleotides and single-base mismatched oligonucleotides, relative to the chemiluminescence intensity in the absence of target and RNaseH. It is a represented graph. Lanes! To 3 are the results in the absence of RNaseH, and lanes 4 to 6 are the results in the presence of RNaseH.

[0115] ここで用いた 1塩基ミスマッチは、比較的安定な"ゆらぎ塩基対"である GT塩基対に よるものである。铸型 MB—ルシフェラーゼ mRNA中のターゲット塩基配列と相補的 な領域が 16merと短いため、 RNaseHを使用しない場合は、フルマッチオリゴヌタレ ォチドと GTミスマッチオリゴヌクレオチドとの区別が困難であるが(レーン 2, 3)、 RNa seHを使用することにより、フルマッチオリゴヌクレオチドと GTミスマッチオリゴヌクレオ チドとを明確に区別できることが分かる(レーン 5, 6)。 GT1塩基ミスマッチを検出でき るため、その他の 1塩基ミスマッチは確実に検出できると考えられる。  [0115] The single base mismatch used here is due to GT base pairs, which are relatively stable "fluctuating base pairs". Since the region complementary to the target nucleotide sequence in the truncated MB-luciferase mRNA is as short as 16 mer, it is difficult to distinguish between full match oligonucleotides and GT mismatch oligonucleotides without using RNaseH (lane 2, 3) By using RNa seH, it is clear that full-matched oligonucleotides and GT-mismatched oligonucleotides can be clearly distinguished (lanes 5 and 6). Since GT1 base mismatch can be detected, other single-base mismatches can be reliably detected.

^ I (標的核酸が極少である場合)  ^ I (when the target nucleic acid is very small)

<ルシフェラーゼの翻訳 化学発光解析 >  <Translation of luciferase: Chemiluminescence analysis>

ターゲットの CCR5オリゴデォキシヌクレオチド(45fmol)の存在下又は非存在下で 、 0. 45pmolの上記錡型 MB—ルシフェラーゼ mRNAを含む再構築された E. coli 翻訳溶液 (T7—トランスクリプション/トランスレーションカップノレド、ピュアシステムク ラシック 1、ポストゲノム研究所社)の中で In Vitro翻訳を行った。合計容量 10 μしの 反応混合物を 37°Cで 60分間インキュベートした。ターゲットオリゴデォキシヌクレオ チドの使用モル数は、錡型 MB—ルシフェラーゼ mRNAのモル数の 1000分の 1で ある。 [0116] また、 Tth RNaseH ( lU ;東洋紡績社)を含む反応混合物を用いて上記と同様の 操作を行った。 A reconstructed E. coli translation solution (T7-transcription / trans) containing 0.45 pmol of the above-mentioned type MB-luciferase mRNA in the presence or absence of the target CCR5 oligodeoxynucleotide (45 fmol). In-vitro translation was performed in the Ryge Cup Noredo, Pure System Classic 1, Post Genome Laboratories). A total reaction volume of 10 μl was incubated at 37 ° C. for 60 minutes. The number of moles of target oligonucleotide used is 1/1000 of the number of moles of vertical MB-luciferase mRNA. [0116] The same operation as described above was performed using a reaction mixture containing Tth RNaseH (lU; Toyobo Co., Ltd.).

[0117] ターゲット核酸としては、 CCR5遺伝子の第 620〜637番目の塩基配列を含むオリ ゴヌクレオチド(5 ' -CCGTAAATAAACCTTCAGACCAGAGA-3 ':配列番号 8 )をフルマッチオリゴデォキシヌクレオチドとして用いた。  [0117] As the target nucleic acid, an oligonucleotide (5'-CCGTAAATAAACCTTCAGACCAGAGA-3 ': SEQ ID NO: 8) containing the 620th to 637th nucleotide sequences of the CCR5 gene was used as a full-matched oligonucleotide.

各サンプルを翻訳後、 2. 5 μ Lを 100 μ Lのルシフェラーゼアツセィ試薬(プロメガ社 )と混合した。 102. を 96穴プレートに移して LumatLB9507を用いて化学発 光強度を測定した。  After translation of each sample, 2.5 μL was mixed with 100 μL of Luciferase Atsey Reagent (Promega). 102. was transferred to a 96-well plate and the chemical emission intensity was measured using Lumat LB9507.

[0118] 結果を図 8に示す。レーン 1及び 2は RNaseH存在下での結果であり、レーン 3及び 4は RNaseH非存在下での結果である。ターゲットが非常に少ない場合でも、 RNas eHを使用することにより、ターゲットが存在しない場合に比べて非常に強い化学発光 が観察された。極少量のターゲットによりノレシフェラーゼの転写、翻訳が検出できたこ とが分かる。  [0118] The results are shown in FIG. Lanes 1 and 2 are the results in the presence of RNaseH, and lanes 3 and 4 are the results in the absence of RNaseH. Even when the number of targets was very small, by using RNase e, very strong chemiluminescence was observed compared to the case where no target was present. It can be seen that transcription and translation of noreciferase were detected with a very small amount of target.

実施例 8 ( β ガラクトシダーゼを用いた検出)  Example 8 (Detection using β-galactosidase)

< MB制御された 8 ガラクトシダーゼ発現鎳型の構築 >  <Construction of MB-regulated 8-galactosidase expression type>

PCRプライマーとして以下のものを用いた他は実施例 1と同様にして、 MB 制御 された ;3—ガラクトシダーゼ mRNA転写用の dsDNAを得た。この 2本鎖 DNAから 転写される β ガラクトシダーゼ mRNAは、ルシフェラーゼをコードする mRNAに代 えて i3—ガラクトシダーゼをコードする mRNAを有する。また、標的核酸配列とハイ ブリダィズできる領域として、 CCR5の第 620〜637番目の塩基配列(5'— AATAA ACCTTCAGACCAG— 3' :配列番号 9)に相補的な配列を有する。その他は、実施 例 1で得た 2本鎖 DNA力、ら得られるルシフェラーゼ mRNAと同様である。  MB-controlled dsDNA for 3-galactosidase mRNA transcription was obtained in the same manner as Example 1 except that the following PCR primers were used. The β-galactosidase mRNA transcribed from this double-stranded DNA has an mRNA encoding i3-galactosidase in place of the mRNA encoding luciferase. Further, as a region that can be hybridized with the target nucleic acid sequence, it has a sequence complementary to the 620th to 637th base sequences of CCR5 (5′—AATAA ACCTTCAGACCAG—3 ′: SEQ ID NO: 9). Others are the same as the double-stranded DNA strength obtained in Example 1 and the obtained luciferase mRNA.

第 1回目 PCR  1st PCR

フォワードプライマー(5,_d(GGT CTG AAG GTT TAT TAG AAG GAG ATA TAC CAA TGA CCA TGA TTA CGG ATT CAC)- 3 ':配列番号 12)  Forward primer (5, _d (GGT CTG AAG GTT TAT TAG AAG GAG ATA TAC CAA TGA CCA TGA TTA CGG ATT CAC) -3 ': SEQ ID NO: 12)

リバースプライマー(5'_d(GGA TTA GTT ATT CAT TAT TTT TGA CAC CAG AC C AAO-3 ':配列番号 13)  Reverse primer (5'_d (GGA TTA GTT ATT CAT TAT TTT TGA CAC CAG AC C AAO-3 ': SEQ ID NO: 13)

第 2回目 PCR フォワードプライマー(5,-d(GAA ATT AAT ACG ACT CAC TAT AGG GAG ACC ACA ACG GTT TCC CTC TAT CTC CTG GTC TGA AGG TTT ATT AG)- 3,:配 列番号 14) 2nd PCR Forward primer (5, -d (GAA ATT AAT ACG ACT CAC TAT AGG GAG ACC ACA ACG GTT TCC CTC TAT CTC CTG GTC TGA AGG TTT ATT AG) -3, sequence number 14)

リバースプライマー( 5,_d(GGA TTA GTT ATT CAT TAT TTT TGA CAC CAG A Reverse primer (5, _d (GGA TTA GTT ATT CAT TAT TTT TGA CAC CAG A

CC AAO-3 ':配列番号 13) CC AAO-3 ': SEQ ID NO: 13)

< R一ガラクトシダーゼの翻訳 ^色 >  <Translation of R-galactosidase ^ color>

ターゲットの CCR5オリゴデォキシヌクレオチド(18pmol)の存在下又は非存在下 で、 0. 2pmolの上記 MB— β—ガラタトシダーゼ dsDNAを含む再構築された E. co li翻訳溶液 (T7 _トランスクリプション/トランスレーションカップルド、ピュアシステム クラシック 1、ポストゲノム研究所社)の中で In Vitro翻訳を行った。合計容量 10 μ L の反応混合物を 37°Cで 60分間インキュベートした。  Reconstructed E. coli translation solution containing 0.2 pmol of MB-β-galatatosidase dsDNA in the presence or absence of target CCR5 oligodeoxynucleotide (18 pmol) (T7_transcription / Translations were performed in Translation Coupled, Pure System Classic 1, Post Genome Laboratories. A total volume of 10 μL of the reaction mixture was incubated at 37 ° C. for 60 minutes.

[0119] また、 Tth RNaseH d U ;東洋紡績社)を含む反応混合物を用いて上記と同様の 操作を行った。 [0119] Further, the same operation as described above was performed using a reaction mixture containing Tth RNaseHdU (Toyobo Co., Ltd.).

[0120] ターゲット核酸としては、 CCR5遺伝子の第 620〜637番目の塩基配列を含むオリ ゴヌクレオチド(5 ' -CCGTAAATAAACCTTCAGACCAGAGA-3 ':配列番号 8 )をフルマッチオリゴデォキシヌクレオチドとして用いた。  [0120] As the target nucleic acid, an oligonucleotide (5'-CCGTAAATAAACCTTCAGACCAGAGA-3 ': SEQ ID NO: 8) containing the 620th to 637th base sequences of the CCR5 gene was used as a full-matched oligonucleotide.

[0121] 各サンプルを翻訳後、 ガラクトシダーゼ酵素アツセィシステム(プロメガ社)を用 い添付プロトコールに従って i3—ガラクトシダーゼ活性を測定した。但し、 1 1 /i Lの 翻訳溶液を、 39 μ Lの 1 Xレポーター溶解バッファー、及び ο 二トロフエニノレー β D ガラクトピラノシド(ONPG)を含む 50 μ Lのアツセィ 2 Xバッファーと混合した。  [0121] After translating each sample, i3-galactosidase activity was measured using the galactosidase enzyme assembly system (Promega) according to the attached protocol. However, 1 1 / i L of the translation solution was mixed with 39 μL of 1 X reporter lysis buffer and 50 μL of Atsy 2 X buffer containing οnitrofenenore β D galactopyranoside (ONPG).

[0122] 結果を図 9 (Α)に示す。レーン 1及び 2は RNaseH非存在下での結果であり、レー ン 3及び 4は RNaseH存在下での結果である。フルマツチターゲットが存在する場合 、ターゲットが存在しなレ、場合に比べてニトロフエノールの生成による 405nmにおけ る強い吸収が観察された。また、 RNaseHを使用することにより、ターゲットが存在し ない場合との区別が一層明確になった。  [0122] The results are shown in Fig. 9 (Α). Lanes 1 and 2 are the results in the absence of RNaseH, and lanes 3 and 4 are the results in the presence of RNaseH. In the presence of a full-match target, a stronger absorption at 405 nm due to the formation of nitrophenol was observed compared to the absence of the target. In addition, the use of RNaseH made it clearer from the case where no target was present.

また、 β—ガラタトシダーゼによる発色の様子を図 9 (B)に示す。 2及び 3は RNaseH を使用する場合であり、 2はターゲットが存在しない場合、 3はフルマツチターゲットが 存在する場合である。 4及び 5は RNaseHを使用しない場合であり、 4はターゲットが 存在しない場合、 5はフルマツチターゲットが存在する場合である。なお、 1は 4と同じ である。 1 , 2は透明であるが、 3は強く黄色に発色していた。また 4は透明であるが、 5 は黄色に発色していた。すなわち、フルマツチターゲットの存在によりターゲットが存 在しない場合に比べて強い発色が観察された。また、 RNaseHを使用することにより ターゲットが存在しない場合との区別が一層明確になった。反応生成物であるニトロ フエノールは可視域に吸収を有するため、レポーター遺伝子として j3 _ガラクトシダ ーゼ遺伝子を用いれば、特別な装置を用いることなく目視によりターゲットの検出を 行える。 Figure 9 (B) shows the color development by β-galatatosidase. 2 and 3 are when RNaseH is used, 2 is when the target is not present, and 3 is when the full-match target is present. 4 and 5 are when RNaseH is not used, and 4 is the target If not, 5 is when a full-match target is present. 1 is the same as 4. 1 and 2 were transparent, but 3 was strongly yellow. 4 was transparent but 5 was colored yellow. In other words, strong color development was observed due to the presence of the full-match target compared to the case where the target did not exist. In addition, the use of RNaseH made it more distinct from the case where no target was present. Since the reaction product nitrophenol absorbs in the visible region, the target can be detected visually without using a special device if the j3_galactosidase gene is used as the reporter gene.

Claims

請求の範囲 The scope of the claims [1] 標的核酸配列とハイブリダィズできる領域、リボソーム結合領域、開始コドン、及びレ ポータータンパク質をコードする領域を備える遺伝子検出用試薬であって、前記標 的核酸とのハイブリダィズにより高次構造変化が誘起され、レポータータンパク質へ の翻訳が開始される遺伝子検出用試薬。  [1] A gene detection reagent comprising a region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, and a higher-order structural change is induced by hybridization with the target nucleic acid. A gene detection reagent that is translated into a reporter protein. [2] 少なくとも、リボソーム結合領域、開始コドン、及びレポータータンパク質をコードする 領域力 ¾NAである請求項 1に記載の遺伝子検出用試薬。  [2] The gene detection reagent according to claim 1, which has at least a region strength NA encoding a ribosome binding region, an initiation codon, and a reporter protein. [3] リボソーム結合領域にリボソームが結合できない状態にあり、標的核酸とハイブリダィ ズできる領域と標的核酸とのハイブリダィズにより誘起される高次構造変化カ^ボソ一 ム結合領域へのリボソームの結合を可能にしてレポータータンパク質への翻訳を開 始させるものである請求項 2に記載の遺伝子検出用試薬。 [3] The ribosome cannot bind to the ribosome binding region, and the ribosome can bind to the higher-order structural change cabsome binding region induced by hybridization between the target nucleic acid and the target nucleic acid. The gene detection reagent according to claim 2, which initiates translation into a reporter protein. [4] 上流より順に、リボソーム結合領域、開始コドン、及びレポータータンパク質をコード する領域を備え、リボソーム結合領域のさらに上流に、標的核酸配列とハイブリダィ ズできる領域を介して、リボソーム結合領域を含む領域とハイブリダィズできる領域を 備えるものである請求項 3に記載の遺伝子検出用試薬。 [4] A region comprising a ribosome binding region, an initiation codon, and a region encoding a reporter protein in order from upstream, and a region including the ribosome binding region further upstream of the ribosome binding region via a region capable of hybridizing with the target nucleic acid sequence. 4. The gene detection reagent according to claim 3, comprising a region capable of hybridizing with the gene. [5] リボソーム結合領域を含む領域とハイブリダィズできる領域の塩基数に対する、標的 核酸配列とハイブリダィズできる領域の塩基数の比率が 1〜: 10である請求項 4に記 載の遺伝子検出用試薬。 [5] The gene detection reagent according to claim 4, wherein the ratio of the number of bases in the region hybridizable to the target nucleic acid sequence to the number of bases in the region hybridizable to the region including the ribosome binding region is 1 to 10: [6] リボソーム結合領域を含む領域とハイブリダィズできる領域が 5〜30塩基からなり、標 的核酸配列とハイブリダィズできる領域が 5〜60塩基からなる請求項 4に記載の遺伝 子検出用試薬。 [6] The gene detection reagent according to claim 4, wherein the region capable of hybridizing with a region including a ribosome binding region comprises 5 to 30 bases, and the region capable of hybridizing with a target nucleic acid sequence comprises 5 to 60 bases. [7] 標的核酸配列とハイブリダィズできる領域が、標的核酸配列と相補的な領域である請 求項 1に記載の遺伝子検出用試薬。  [7] The reagent for gene detection according to claim 1, wherein the region capable of hybridizing with the target nucleic acid sequence is a region complementary to the target nucleic acid sequence. [8] 標的核酸とハイブリダィズした場合に自己切断するリボザィムとして機能する領域を 含むものである請求項 1に記載の遺伝子検出用試薬。 [8] The gene detection reagent according to claim 1, comprising a region that functions as a ribozyme that self-cleaves when hybridized with a target nucleic acid. [9] レポータータンパク質が酵素である請求項 1に記載の遺伝子検出用試薬。 [9] The reagent for gene detection according to claim 1, wherein the reporter protein is an enzyme. [10] 前記酵素が可視光を発生する物質の生産に関与するものである請求項 9に記載の 遺伝子検出用試薬。 10. The gene detection reagent according to claim 9, wherein the enzyme is involved in the production of a substance that generates visible light. [11] 標的核酸配列とハイブリダィズできる領域、リボソーム結合領域、開始コドン、及びレ ポータータンパク質をコードする領域を備え、標的核酸とのハイブリダィズにより誘起 される高次構造変化がレポータータンパク質への翻訳を開始させる RNAに転写され 得る DNAを含む遺伝子検出用試薬。 [11] Equipped with a region that can hybridize with the target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding the reporter protein, and higher-order structural changes induced by hybridization with the target nucleic acid initiate translation into the reporter protein Reagent for gene detection containing DNA that can be transcribed into RNA. [12] 前記 RNAが、リボソーム結合領域にリボソームが結合できない状態にあり、標的核酸 とハイブリダィズできる領域と標的核酸とのハイブリダィズにより誘起される高次構造 変化がリボソーム結合領域へのリボソームの結合を可能にしてレポータータンパク質 への翻訳を開始させるものである請求項 11に記載の遺伝子検出用試薬。  [12] The RNA is in a state where the ribosome cannot bind to the ribosome binding region, and the conformational change induced by hybridization between the target nucleic acid and the target nucleic acid can bind the ribosome to the ribosome binding region. 12. The gene detection reagent according to claim 11, which initiates translation into a reporter protein. [13] 前記 RNAが、上流より順に、リボソーム結合領域、開始コドン、及びレポータータン パク質をコードする領域を備え、リボソーム結合領域のさらに上流に、標的核酸配列 とハイブリダィズできる領域を介して、リボソーム結合領域を含む領域とハイブリダィズ できる領域を備えるものである請求項 12に記載の遺伝子検出用試薬。  [13] The RNA comprises a region encoding a ribosome binding region, an initiation codon, and a reporter protein in order from upstream, and further upstream of the ribosome binding region via a region capable of hybridizing with a target nucleic acid sequence. 13. The gene detection reagent according to claim 12, comprising a region capable of hybridizing with a region containing a binding region. [14] リボソーム結合領域を含む領域とハイブリダィズできる領域の塩基数に対する、標的 核酸配列とハイブリダィズできる領域の塩基数の比率が 1〜: 10である請求項 13に記 載の遺伝子検出用試薬。  [14] The reagent for gene detection according to claim 13, wherein the ratio of the number of bases in the region hybridizable with the target nucleic acid sequence to the number of bases in the region hybridizable with the region including the ribosome binding region is 1 to 10: [15] リボソーム結合領域を含む領域とハイブリダィズできる領域が 5〜30塩基からなり、標 的核酸配列とハイブリダィズできる領域が 5〜60塩基からなる請求項 13に記載の遺 伝子検出用試薬。  15. The gene detection reagent according to claim 13, wherein the region capable of hybridizing with a region containing a ribosome binding region comprises 5 to 30 bases, and the region capable of hybridizing with a target nucleic acid sequence comprises 5 to 60 bases. [16] 標的核酸配列とハイブリダィズできる領域が、標的核酸配列と相補的な領域である請 求項 11に記載の遺伝子検出用試薬。  [16] The gene detection reagent according to claim 11, wherein the region capable of hybridizing with the target nucleic acid sequence is a region complementary to the target nucleic acid sequence. [17] 前記 RNAが、標的核酸とハイブリダィズした場合に自己切断するリボザィムとして機 能する領域を含むものである請求項 11に記載の遺伝子検出用試薬。 [17] The reagent for gene detection according to [11], wherein the RNA includes a region that functions as a ribozyme that self-cleaves when hybridized with a target nucleic acid. [18] レポータータンパク質が酵素である請求項 11に記載の遺伝子検出用試薬。 18. The gene detection reagent according to claim 11, wherein the reporter protein is an enzyme. [19] 前記酵素が可視光を発生する物質の生産に関与するものである請求項 18に記載の 遺伝子検出用試薬。 [19] The gene detection reagent according to [18], wherein the enzyme is involved in the production of a substance that generates visible light. [20] 請求項 1に記載の遺伝子検出用試薬を備える遺伝子検出用キット。 [20] A gene detection kit comprising the gene detection reagent according to claim 1. [21] さらに、原核細胞抽出液を備える請求項 20に記載の遺伝子検出用キット。 21. The gene detection kit according to claim 20, further comprising a prokaryotic cell extract. [22] さらに、 DNAとハイブリダィズした RNAを特異的に切断する RNA分解酵素を備える 請求項 20に記載の遺伝子検出用キット。 [22] In addition, an RNase that specifically cleaves RNA hybridized with DNA is provided. The gene detection kit according to claim 20. [23] 請求項 11に記載の遺伝子検出用試薬を備える遺伝子検出用キット。  [23] A gene detection kit comprising the gene detection reagent according to claim 11. [24] さらに、原核細胞抽出液を備える請求項 23に記載の遺伝子検出用キット。  24. The gene detection kit according to claim 23, further comprising a prokaryotic cell extract. [25] さらに、 DNAとハイブリダィズした RNAを特異的に切断する RNA分解酵素を備える 請求項 23に記載の遺伝子検出用キット。  25. The gene detection kit according to claim 23, further comprising an RNase that specifically cleaves RNA hybridized with DNA. [26] 被験試料と請求項 1に記載の遺伝子検出用試薬とを混合する第 1工程と、遺伝子検 出用試薬からのレポータータンパク質の発現量を、被験試料の非存在下での請求項 1に記載の遺伝子検出用試薬からのレポータータンパク質の発現量と比較することに より、被験試料中の標的核酸の有無を判定する第 2工程とを含む遺伝子検出方法。  [26] The first step of mixing the test sample and the gene detection reagent according to claim 1, and the expression level of the reporter protein from the gene detection reagent in the absence of the test sample. And a second step of determining the presence or absence of the target nucleic acid in the test sample by comparing the expression level of the reporter protein from the gene detection reagent described in 1. [27] 遺伝子検出用試薬からのレポータータンパク質の発現を原核細胞抽出液の存在下 で行う請求項 26に記載の方法。  [27] The method according to claim 26, wherein the expression of the reporter protein from the gene detection reagent is carried out in the presence of a prokaryotic cell extract. [28] 第 1工程において、被験試料と、請求項 1に記載の遺伝子検出用試薬と、 DNAとハ イブリダィズした RNAを特異的に切断する RNA分解酵素とを混合する工程を含む 請求項 26に記載の方法。  [28] The first step includes a step of mixing the test sample, the gene detection reagent according to claim 1, and an RNase that specifically cleaves the hybridized RNA with DNA. The method described. [29] 被験試料と請求項 11に記載の遺伝子検出用試薬とを混合する第 1工程と、遺伝子 検出用試薬からのレポータータンパク質の発現量を、被験試料の非存在下での請求 項 11に記載の遺伝子検出用試薬からのレポータータンパク質の発現量と比較するこ とにより、被験試料中の標的核酸の有無を判定する第 2工程とを含む遺伝子検出方 法。  [29] The first step of mixing the test sample with the gene detection reagent according to claim 11, and the expression level of the reporter protein from the gene detection reagent according to claim 11 in the absence of the test sample. A gene detection method comprising a second step of determining the presence or absence of a target nucleic acid in a test sample by comparing with the expression level of a reporter protein from the gene detection reagent described. [30] 遺伝子検出用試薬からのレポータータンパク質の発現を原核細胞抽出液の存在下 で行う請求項 29に記載の方法。  [30] The method of claim 29, wherein the reporter protein is expressed from the gene detection reagent in the presence of a prokaryotic cell extract. [31] 第 1工程において、被験試料と、請求項 1に記載の遺伝子検出用試薬と、 DNAとハ イブリダィズした RNAを特異的に切断する RNA分解酵素とを混合する工程を含む 請求項 29に記載の方法。  [31] The first step includes the step of mixing the test sample, the gene detection reagent according to claim 1, and an RNase that specifically cleaves the hybridized RNA with DNA. The method described. [32] 被験試料と、請求項 1に記載の遺伝子検出用試薬と、 DNAとハイブリダィズした RN Aを特異的に切断する RNA分解酵素とを混合する第 1工程と、遺伝子検出用試薬 力、らのレポータータンパク質の発現量を、被験試料の非存在下での請求項 1に記載 の遺伝子検出用試薬からのレポータータンパク質の発現量と比較することにより、被 験試料中の標的核酸の有無を判定する第 2工程とを含む 1塩基多型の検出方法。 [32] A first step of mixing a test sample, the gene detection reagent according to claim 1 with an RNase that specifically cleaves RNA hybridized with DNA, and a gene detection reagent By comparing the expression level of the reporter protein in the absence of the test sample with the expression level of the reporter protein from the reagent for gene detection according to claim 1. A method for detecting a single nucleotide polymorphism comprising a second step of determining the presence or absence of a target nucleic acid in a test sample. [33] 被験試料と、請求項 11に記載の遺伝子検出用試薬と、 DNAとハイブリダィズした R [33] A test sample, the gene detection reagent according to claim 11, and R hybridized with DNA NAを特異的に切断する RNA分解酵素とを混合する第 1工程と、遺伝子検出用試薬 力、らのレポータータンパク質の発現量を、被験試料の非存在下での請求項 11に記 載の遺伝子検出用試薬からのレポータータンパク質の発現量と比較することにより、 被験試料中の標的核酸の有無を判定する第 2工程とを含む 1塩基多型の検出方法。 The gene according to claim 11, wherein the first step of mixing with an RNase that specifically cleaves NA and the expression level of the reporter protein in the absence of the test sample are determined using the reagent for detecting the gene and the expression level of the reporter protein. A single nucleotide polymorphism detection method comprising a second step of determining the presence or absence of a target nucleic acid in a test sample by comparing with the expression level of a reporter protein from a detection reagent. [34] 標的核酸配列とハイブリダィズできる領域、リボソーム結合領域、開始コドン、及びレ ポータータンパク質をコードする領域を備える核酸であって、前記標的核酸とのハイ ブリダィズにより高次構造変化が誘起され、レポータータンパク質への翻訳が開始さ れる核酸の遺伝子検出用試薬としての使用。  [34] A nucleic acid comprising a region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, wherein a conformation change is induced by hybridization with the target nucleic acid, and the reporter Use of a nucleic acid that begins translation into a protein as a gene detection reagent. [35] 標的核酸配列とハイブリダィズできる領域、リボソーム結合領域、開始コドン、及びレ ポータータンパク質をコードする領域を備える RNAであり、標的核酸とのハイブリダィ ズにより誘起される高次構造変化がレポータータンパク質への翻訳を開始させる RN Aに転写され得る DNAの遺伝子検出用試薬としての使用。 [35] RNA comprising a region capable of hybridizing with a target nucleic acid sequence, a ribosome binding region, an initiation codon, and a region encoding a reporter protein, and a conformational change induced by hybridization with the target nucleic acid to the reporter protein Use as a gene detection reagent for DNA that can be transcribed into RNA that initiates translation of RNA.
PCT/JP2006/302896 2005-02-18 2006-02-17 Gene detection reagent and the use thereof Ceased WO2006088165A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007503761A JPWO2006088165A1 (en) 2005-02-18 2006-02-17 Gene detection reagent and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005043104 2005-02-18
JP2005-043104 2005-02-18

Publications (1)

Publication Number Publication Date
WO2006088165A1 true WO2006088165A1 (en) 2006-08-24

Family

ID=36916562

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/302896 Ceased WO2006088165A1 (en) 2005-02-18 2006-02-17 Gene detection reagent and the use thereof

Country Status (2)

Country Link
JP (1) JPWO2006088165A1 (en)
WO (1) WO2006088165A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329889B2 (en) 2008-02-15 2012-12-11 Trustees Of Boston University In vivo gene sensors
JP2015533297A (en) * 2012-11-06 2015-11-24 プレジデント アンド フェローズ オブ ハーバード カレッジ Riboregulator composition and method of use
US11124846B2 (en) 2014-07-14 2021-09-21 President And Fellows Of Harvard College Compositions comprising riboregulators and methods of use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004046321A2 (en) * 2002-11-15 2004-06-03 Trustees Of Boston University Cis/trans riboregulators

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004046321A2 (en) * 2002-11-15 2004-06-03 Trustees Of Boston University Cis/trans riboregulators

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BROUDE N.E. ET AL.: "Stem-loop oligonucleotides: a robust tool for molecular biology and biotechnology", TRENDS IN BIOTECHNOL., vol. 20, no. 6, June 2002 (2002-06-01), pages 249 - 256, XP002342762 *
GOEL G. ET AL.: "Molecular beacon: a multitask", J. APPL. MICROBIOL., vol. 99, no. 3, 2005, pages 435 - 442, XP003002039 *
ISAACS F.J. ET AL.: "Engineered riboregulators enable post-transcriptional control of gene expression", NAT. BIOTECHNOL., vol. 22, no. 7, July 2004 (2004-07-01), pages 841 - 847, XP003002036 *
MAJDALANI N. ET AL.: "DsrA RNA regulates translation of Rpos message by an anti-antisense mechanism, independent of its action as an antisilencer of transcription", PROC. NATL. ACAD. SCI. USA, vol. 95, no. 21, 13 October 1998 (1998-10-13), pages 12462 - 12467, XP003002037 *
NARITA A. ET AL.: "CIS Sayogata Kakusan no Koji Kozo Henka o Riyo shita Idenshi Shindanho", CSJ: THE CHEMICAL SOCIETY OF JAPAN DAI 85 SHUNKI NENKAI KOEN YOKOSHU II, 11 March 2005 (2005-03-11), pages 1387 (4G6-27), XP003002040 *
REPOILA F. ET AL.: "Small non-coding RNAs, co-ordinators of adaptation processes in Escherichia coli: the Rpos paradigm", MOL. MICROBIOL., vol. 48, no. 4, May 2003 (2003-05-01), pages 855 - 861, XP003002038 *
SANDO S. ET AL.: "Amplified nucleic acid sensing using programmed self-cleaving DNAzyme", J. AM. CHEM. SOC., vol. 125, no. 51, 24 December 2003 (2003-12-24), pages 15720 - 15721, XP002986218 *
SANDO S. ET AL.: "Doubly catalytic sensing of HIV-1-related CCR5 sequence in prokaryotic cell-free translation system using riboregulator-controlled luciferase activity", J. AM. CHEM. SOC., vol. 127, no. 15, 20 April 2005 (2005-04-20), pages 5300 - 5301, XP003002041 *
TAN W. ET AL.: "Molecular beacons", CURR. OPIN. CHEM. BIOL., vol. 8, no. 5, October 2004 (2004-10-01), pages 547 - 553, XP004576568 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329889B2 (en) 2008-02-15 2012-12-11 Trustees Of Boston University In vivo gene sensors
WO2009137136A3 (en) * 2008-02-15 2013-03-21 Trustees Of Boston University In vivo gene sensors
US8795958B2 (en) 2008-02-15 2014-08-05 Trustees Of Boston University In vivo gene sensors
JP2015533297A (en) * 2012-11-06 2015-11-24 プレジデント アンド フェローズ オブ ハーバード カレッジ Riboregulator composition and method of use
JP2017118881A (en) * 2012-11-06 2017-07-06 プレジデント アンド フェローズ オブ ハーバード カレッジ Riboregulator composition and method of use
US11124846B2 (en) 2014-07-14 2021-09-21 President And Fellows Of Harvard College Compositions comprising riboregulators and methods of use thereof
US11788156B2 (en) 2014-07-14 2023-10-17 President And Fellows Of Harvard College Compositions comprising riboregulators and methods of use thereof

Also Published As

Publication number Publication date
JPWO2006088165A1 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
AU2018299445B2 (en) Application of Cas protein, method for detecting target nucleic acid molecule and kit
US7851150B2 (en) Detection of small nucleic acids
US8206904B2 (en) Detection of nucleic acids
AU2012203393B9 (en) Detection of nucleic acids
CA2770588C (en) Target discriminative probe(td) having modified dual specificity oligonucleotide(mdso) and uses thereof
EP2361991A1 (en) Detection of small nucleic acids
KR101589483B1 (en) Method for Detection of Nucleic Acids by Asymmetric Isothermal Amplification of Nucleic Acids and Signal Probe
JP6638122B2 (en) Target nucleic acid detection method and kit
EP2014774A1 (en) Assay for the simulataneous detection of multiple nucleic acid sequences in a sample
CN104164478A (en) CRAS-PCR detection method of single base mutation of gene
Rahimi et al. CRISPR-Cas target recognition for sensing viral and cancer biomarkers
Lu et al. Rapid and highly specific detection of communicable pathogens using one-pot loop probe-mediated isothermal amplification (oLAMP)
WO2006088165A1 (en) Gene detection reagent and the use thereof
AU2012200597B2 (en) Detection of small nucleic acids
AU2008201522B2 (en) Detection of small nucleic acids
CA2847588A1 (en) Detection of small nucleic acids
HK1245352A1 (en) Method for the simultaneous detection of multiple nucleic acid sequences in a sample
HK1178575A (en) Detection of nucleic acids by an improved invader assay

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007503761

Country of ref document: JP

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06714037

Country of ref document: EP

Kind code of ref document: A1